10-K
1
form10-k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-K
[X]
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE
ACT OF 1934
For
the Fiscal Year Ended September 30, 2020
OR
[ ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE
ACT OF 1934
For
the transition period from N/A to N/A
Commission
File Number: 000-28745
Cipherloc
Corporation
(Name
of small business issuer as specified in its charter)
Texas
86-0837077
State
of Incorporation
IRS
Employer Identification No.
6836
Bee Cave Road, Bldg. 1, S#279
Austin,
TX 78746
(Address
of principal executive offices)
(512)
649-7700
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act: None.
Securities
registered pursuant to Section 12(g) of the Act:
Common
Stock, par value $0.01
(Title
of Class)
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. [ ]
Yes [X] No
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. [ ]
Yes [X] No
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X]
No [ ]
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not
contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large
accelerated filer
[ ]
Accelerated
filer
[ ]
Non–Accelerated
filer
[X]
Small
reporting company
[X]
Emerging
growth company
[ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Indicate
by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. [ ]
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Exchange Act). Yes [ ]
No [X]
On
March 31, 2020, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market
value of the Common Stock held by non-affiliates of the registrant was $22,051,118 based upon the closing price on that date of
the common stock of the registrant on the OTCQB Venture Market of $0.85.
As
of December 23, 2020, there were 27,505,196 shares of the issuer’s common stock, par value $0.01 per share, issued
and outstanding.
CIPHERLOC
CORPORATION
FORM
10-K ANNUAL REPORT
FOR
THE FISCAL YEARS ENDED SEPTEMBER 30, 2020 AND 2019
TABLE
OF CONTENTS
PART
I
ITEM
1.
BUSINESS
2
ITEM
1A.
RISK
FACTORS
4
ITEM
1B.
UNRESOLVED
STAFF COMMENTS
7
ITEM
2.
PROPERTIES
7
ITEM
3.
LEGAL
PROCEEDINGS
7
ITEM
4.
MINE
SAFETY DISCLOSURES
7
PART
II
ITEM
5.
MARKET
FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
8
ITEM
6.
SELECTED
FINANCIAL DATA
8
ITEM
7.
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
9
ITEM
7A.
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
12
ITEM
8.
FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA
13
ITEM
9.
CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
32
ITEM
9A.
CONTROLS
AND PROCEDURES
32
ITEM
9B.
OTHER
INFORMATION
33
PART
III
ITEM
10.
DIRECTORS,
EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE
34
ITEM
11.
EXECUTIVE
COMPENSATION
39
ITEM
12.
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
43
ITEM
13.
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
44
ITEM
14.
PRINCIPAL
ACCOUNTANT FEES AND SERVICES
44
PART
IV
ITEM
15.
EXHIBITS
AND FINANCIAL STATEMENT SCHEDULES
45
SIGNATURES
46
Special
Note Regarding Forward-Looking Statements
Some
of our statements under “Business,” “Properties,” “Legal Proceedings,” “Management’s
Discussion and Analysis of Financial Condition and Results of Operations,” the Notes to Financial Statements and elsewhere
in this Annual Report on Form 10-K constitute “forward-looking statements.” In some cases, forward-looking statements
are identified by terminology such as “may,” “will,” “should,” “could,” “would,”
“expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,”
“approximates,” “predicts,” “potential” or “continue” or the negative of such
terms and other comparable terminology. Forward-looking statements usually relate to future events and anticipated revenues, earnings,
cash flows or other aspects of our operations or operating results. Forward-looking statements generally include statements containing:
●
projections
about accounting and finances;
●
plans
and objectives for the future;
●
projections
or estimates about assumptions relating to our performance; or
●
our
opinions, views or beliefs about the effects of current or future events, circumstances or performance.
You
should view these statements with caution. Those statements are not guaranteeing future performance, circumstances or events.
They are based on facts and circumstances known to us as of the date the statements are made. All phases of our business are subject
to uncertainties, risks and other influences, many of which we do not control. Any of these factors either alone or taken together,
could have a material adverse effect on us and could change whether any forward-looking statement ultimately turns out to be true.
Additionally, we assume no obligation to update any forward-looking statement as a result of future events, circumstances or developments.
1
PART
I
ITEM
1. BUSINESS
Overview
Cipherloc
Corporation (the “Company” or “Cipherloc”) was incorporated in the State of Texas on June 22, 1953 as
American Mortgage Company. Effective August 27, 2014, we changed our name to Cipherloc Corporation. Our headquarters are located
at 6836 Bee Cave Road, Building 1, S#279, Austin, TX 78746. Our website is www.cipherloc.net . The information contained,
or referred to, on our website is not part of this Annual Report on Form 10-K unless expressly noted.
Business
Strategy
We
are developing products and services around our patented polymorphic encryption technology designed to enable a more efficient
and stronger layer of protection to be added to existing solutions. Through a licensing program, we anticipate offering the first
secure commercially viable advanced “Polymorphic Encryption Core” (“PEC”) software developers kit to be
used in any commercial data security industry and/or in sensitive applications.
Our
innovative and patented polymorphic technology eliminates the flaws and inadequacies associated with today’s encryption
algorithms. Instead of dealing with large monolithic blocks of data, our approach decomposes the information to be protected into
multiple segments. These individual segments each have a unique encryption key, utilize different encryption algorithms, are randomly
grouped into different lengths, and can be further re-encrypted. Since segments are independent from each other and are individually
protected, our technology is not susceptible to computational attacks. In fact, the strength of our technology improves as compute
power increases.
Products
and Services
During
2018 and 2019, we attempted to market several products, services and solutions. The initial solution suite was marketed under
several product names. CipherLoc EDGE, a solution to be installed on mobile/handset devices, was designed to enable data to be
securely sent between any two mobile devices. CipherLoc ENTERPRISE, a solution to be installed on desktops, laptops and tablet
computers, was designed to enable data to be securely sent between any two platforms. CipherLoc GATEWAY, a solution to be installed
on servers, was designed to enable end-to-end data protection to and from servers, computers, tablets, and/or mobile devices via
the GATEWAY-protected servers. CipherLoc SHIELD was designed as a solution to be used as a data storage platform.
During
2018 and 2019, there were forward-looking public announcements by the Company’s then-management of product names or segments
that were not delivered to the market and are not presently available to customers. Our current management restructured the Company
to invest material resources into only products and services that are deliverable, have viable economic potential, and may be
publicly disclosed without adversely affecting our competitive position. The core of our product and service offerings will continue
to be built around our patents and our polymorphic encryption technology ,which is a highly secure, quantum-ready data protection
technology carrying FIPS 140-2 (Federal Information Processing Standard 140-2) validation certificate #3381 for the “CipherLoc
Polymorphic Encryption Engine Core” solution by the National Institute of Standards and Technology (NIST). We focused our
development efforts during 2020 to develop commercial application of its technology by advancing a Software Development Kit (“SDK”)
for the Polymorphic Encryption Core. By doing so, we have allowed potential customers to integrate and configure the PEC using
the SDK.
Research
and Development
Our
research and development expenditures for the years ended September 30, 2020 and 2019 were $1,689,455 and $1,744,480, respectively.
During December 2019, management determined that the maturity of our patented technology justified a cessation of academic research
activity and the elimination of the chief scientist’s role leading academic efforts. Cost savings from those actions are
now allocated entirely to product development, product engineering, and revenue-generating sales activity. Management continued
to emphasis these three areas during fiscal year 2020 and intends to do so during fiscal year 2021 as well.
Competition
The
encryption software market sector is highly competitive, subject to rapid change, and significantly affected by new product introductions
and other activities of market participants.
Some
of our competitors in certain markets have greater financial, technical, sales, marketing and other resources than we do. Because
of these and other factors, competitive conditions in these industries are likely to continue to intensify in the future. Increased
competition could result in price reductions, reduced net revenue and profit margins and loss of market share, any of which could
harm our business.
We
believe that our future results depend largely upon our ability to better serve customers and by offering new product enhancements
whether by internal development or acquisition. We also believe we must continue to provide existing product offerings that compete
favorably with respect to ease of use, reliability, performance, range of useful features, reputation, and price.
We
anticipate we will face increasing pricing pressures from competitors in the future. Given that there are low barriers to entry
into the software market and that the market is subject to rapid technological change, we believe that competition will persist
and intensify in the future.
Intellectual
Property
Protective
Measures
Our
intellectual property is an important and vital asset of our company that enables us to develop, market, and sell our products
and services and enhance our competitive position. Intellectual property includes our proprietary business and technical know-how,
inventions, works of authorship, and confidential information. To protect our intellectual property, we rely primarily upon legal
rights in trade secrets, patents, copyrights, and trademarks, in addition to company policies and procedures, security practices,
contracts, and relevant operational measures.
2
We
protect the confidentiality of proprietary information by entering into non-disclosure agreements with our employees, contractors,
and channel and business partners, and we enter into license agreements with respect to our software and proprietary information
that include confidentiality terms. These agreements are generally non-transferable and have either a perpetual or time-limited
term. We also employ access controls and associated security measures to protect our facilities, equipment, and networks.
Patents,
Copyrights, Trademarks, and Licenses
Our
products, particularly our software and related documentation, are protected under U.S. and international copyright laws and laws
related to the protection of intellectual property and proprietary rights. Currently, we have 6 patents, with approximately 5
patents pending with the U.S. Patent and Trademark Office. We employ procedures to label copyrightable works with the appropriate
proprietary rights notices, and we actively enforce these rights in the U.S. and abroad. However, these measures may not provide
adequate protection, and our intellectual property rights may be challenged.
Cipherloc’s
logo, is a registered trademark of the Company in the U.S. In the U.S., we are generally able to maintain our trademark rights
and renew trademark registrations for as long as the trademarks are in use.
Government
Regulations
Export
Control Regulations . It is expected that all our products will be subject to U.S. export control laws and applicable foreign
government import, export and/or use requirements. The level of control generally depends on the nature of the goods and services
in question. For example, the level of control is impacted by the nature of the software and encryption incorporated into our
products. Where controls apply, the export of our products may require an export license or authorization or that the transaction
qualifies for a license exception or the equivalent and may also be subject to corresponding reporting requirements. For the export
of some of our products, we may be subject to various post-shipment reporting requirements. Minimal U.S. export restrictions apply
to all our products, whether or not they perform encryption functions. In the event we become a Department of Defense contractor,
there are certain registration requirements that may be triggered by our sales. In addition, certain of our items and/or transactions
may be subject to the International Traffic in Arms Regulations (ITAR) if our software or services are specifically designed or
modified for defense purposes. Companies engaged in manufacturing or exporting ITAR-controlled goods and services (even if these
companies do not export such items) are required to register with the U.S. State Department.
Enhancements
to existing products may, and new products will, be subject to review under the Export Administration Act to determine what export
classification they will receive. In light of the ongoing discussions regarding anti-terrorism legislation in the U.S. Congress,
there continues to be discussions regarding the correct level of export control. Export regulations may be modified at any time.
Modifications to the export regulations could reduce or eliminate our ability to export some or all of our products from the U.S.
without a license in the future, which could put us at a disadvantage in competing for international sales compared to companies
located outside of the U.S. that would not be subject to these restrictions. Modifications to the export regulations could prevent
us from exporting our existing and future products in an unrestricted manner without a license or make it more difficult to receive
the desired classification. If export regulations were to be modified in such a way, we may be put at a competitive disadvantage
with respect to selling our products internationally. We will complete technical reviews on any new products that we acquire or
develop that may be subject to these regulations before we can export them.
Privacy
Laws . We may be subject to various international, federal and state regulations regarding the treatment and protection
of personally identifying and other regulated information. Applicable laws may include, without limitation, U.S. federal laws
and implementing regulations such as the GLBA and HIPAA, as well as state laws and regulations, and international laws and regulations
including the European Union General Data Protection Regulation, or the GDPR, which replaced the European Union Data Protection
Directive in May 2018. Additionally, some of these laws have requirements on the transmittal of data from one jurisdiction to
another. In the event our systems are compromised by an unauthorized party, many of these privacy laws require that we provide
notices to our customers whose personally identifiable data we reasonably believe may have been compromised. Additionally, if
we transfer data in violation of these laws, we could be subjected to substantial fines. To mitigate the risk of compromised information,
we use encryption and other security to protect our databases.
Personnel
As
of the date of this Annual Report on Form 10-K, we have full-time employee, 1 part-time employee and two full-time contractors.
These low employee and contractor counts reflect the actions made by the Company in March and April to reduce the monthly operating
expenses. The Company has determined this level of staffing is appropriate to continue pursuing applications of its technology
with prospective customers.
WHERE
YOU CAN FIND MORE INFORMATION
You
are advised to read this Form 10-K in conjunction with other reports and documents that we file from time to time with the SEC.
In particular, please read our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that we file from time to time.
You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street,
N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at
1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.
3
ITEM
1A. RISK FACTORS
Outlined
below are some of the risks that we believe could affect our business and financial statements. An investment in our common stock
involves a high degree of risk. You should carefully consider the following information about these risks, together with the other
information contained in this Annual Report on Form 10-K, before investing in our common stock. If any of the events anticipated
by the risks described below occur, our results of operations and financial condition could be adversely affected which could
result in a decline in the market price of our common stock, causing you to lose all or part of your investment.
A
pandemic, epidemic or outbreak of an infectious disease, such as COVID-19, may materially and adversely affect our business and
operations.
On
March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. The COVID-19 pandemic is
affecting the United States and global economies and may affect our operations and those of third parties on which we rely. While
the potential economic impact brought by, and the duration of the COVID-19 pandemic is difficult to assess or predict, the impact
of the COVID-19 pandemic on the global financial markets may reduce our ability to access capital, which could negatively impact
our short-term and long-term liquidity. The ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change.
We do not yet know the full extent of potential delays or impacts on our business, financing or the global economy as a whole.
However, these effects could have a material impact on our liquidity, capital resources, operations and business and those of
the third parties on which we rely.
Because
our common stock is quoted on the OTCQB instead of national exchange, our investors may have a difficulty selling their stock
or may experience negative volatility on the market price of our common stock.
Our
common stock is traded on the OTCQB Venture Market (“OTCQB”) operated by the OTC Markets Group. The OTCQB is often
highly illiquid, in part because it does not have a national quotation system by which potential investors can follow the market
price of shares except through information received and generated by a limited number of broker-dealers that make markets in particular
stocks. There is a greater chance of volatility for securities that trade on the OTCQB as compared to a national exchange or quotation
system. This volatility may be caused by a variety of factors, including the lack of readily available price quotations, the absence
of consistent administrative supervision of bid and ask quotations, lower trading volume, and market conditions. Investors in
our common stock may experience high fluctuations in the market price and volume of the trading market for our securities. These
fluctuations, when they occur, have a negative effect on the market price for our securities. Accordingly, our stockholders may
not be able to realize a fair price from their shares when they determine to sell them or may have to hold them for a substantial
period of time until the market for our common stock improves.
We
depend significantly upon the continued involvement of our present management.
The
Company’s success depends significantly upon the involvement of our present management, who are in charge of our strategic
planning and operations. We may need to attract and retain additional talented individuals in order to carry out our business
objectives. The competition for individuals with expertise in this industry could be intense and there are no assurances that
these individuals will be available to us.
Compliance
with changing regulation of corporate governance and public disclosure will result in additional expenses and pose challenges
for our management.
Changing
laws, regulations and standards relating to corporate governance and public disclosure, including the Dodd-Frank Wall Street Reform
and Consumer Protection Act and the rules and regulations promulgated there under, the Sarbanes-Oxley Act and SEC regulations,
have created uncertainty for public companies and significantly increased the costs and risks associated with accessing the U.S.
public markets. Our management team will need to devote significant time and financial resources to comply with both existing
and evolving standards for public companies, which will lead to increased general and administrative expenses and a diversion
of management time and attention from revenue generating activities to compliance activities.
4
Risks
Related to Our Industry
We
face intense competition.
We
expect to experience intense competition across all markets for our products and services. Although we believe our business and
product portfolio will be a competitive advantage, our competitors that are focused on narrower product lines may be more effective
in devoting technical, marketing, and financial resources to compete with us. In addition, barriers to entry in our businesses
generally are low, and products, once developed, can be distributed broadly and quickly at a relatively low cost. Open-source
software vendors are devoting considerable efforts to developing software that mimics the features and functionality of our anticipated
products. These competitive pressures may result in decreased sales volumes, price reductions, and/or increased operating costs,
such as for marketing and sales incentives, resulting in lower revenue, gross margins, and operating income.
Our
business depends on our ability to attract and retain talented employees.
Our
business is based on successfully attracting and retaining talented employees. The market for highly skilled workers and leaders
in our industry is extremely competitive. If we are less successful in our recruiting efforts, or if we are unable to retain key
employees, our ability to develop and deliver successful products and services may be adversely affected. Effective succession
planning is also important to our long-term success. Failure to ensure effective transfer of knowledge and smooth transitions
involving key employees could hinder our strategic planning and execution.
Delays
in product development schedules may adversely affect our revenues.
The
development of software products is a complex and time-consuming process. New products can require long development and testing
periods. Our increasing focus on innovative and new software presents new and complex development issues. Significant delays in
new product releases or significant problems in creating new products could adversely affect our revenue.
Acquisitions
and joint ventures may have an adverse effect on our business.
If
we made acquisitions or entered into joint ventures as part of our long-term business strategy, these transactions would involve
significant challenges and risks including that the transactions do not advance our business strategy, that we don’t realize
a satisfactory return on our investment, or that we experience difficulty in the integration of new employees, business systems,
and technology, or diversion of management’s attention from our other businesses. These events could harm our operating
results or financial condition.
Risks
Related to Our Securities
The
market price for our common stock may be volatile, and you may not be able to sell our stock at a favorable price or at all.
Many
factors could cause the market price of our common stock to rise and fall, including:
●
actual
or anticipated variations in our quarterly results of operations;
●
changes
in market valuations of companies in our industry;
●
changes
in expectations of future financial performance;
●
fluctuations
in stock market prices and volumes;
●
issuances
of dilutive common stock or other securities in the future;
●
the
addition or departure of key personnel;
5
●
announcements
by us or our competitors of acquisitions, investments or strategic alliances; and
●
it
is possible that the proceeds from sales of our common stock may not equal or exceed the prices you paid for the shares after
including the costs and fees of making the sales
Substantial
sales of our common stock, or the perception that such sales might occur, could depress the market price of our common stock.
We
cannot predict whether future issuances of our common stock or resale in the open market will not decrease the market price of
our common stock. The consequence of any such issuances or resale of our common stock on our market price may be increased as
a result of the fact that our common stock is thinly, or infrequently, traded. The exercise of any options, or the vesting of
any restricted stock that we may grant to directors, executive officers and other employees in the future, the issuance of common
stock in connection with acquisitions and other issuances of our common stock, may decrease the market price of our common stock.
Holders
of our common stock have a risk of potential dilution if we issue additional shares of common stock in the future.
The
exercise of options and warrants and/or the conversion of preferred stock will dilute the shareholder’s ownership percentage.
We may issue options to purchase or grant up to an aggregate of 3,000,000 shares of common stock under our 2019 Stock Grant/Option
Plan. We also have outstanding warrants to purchase 24,290,866 shares of our common stock. In the future, we may grant additional
stock options, warrants, or convertible securities. The exercise or conversion of stock options, warrants, preferred stock, or
convertible securities will dilute the ownership percentage of our other stockholders. The dilutive effect of the exercise or
conversion of these securities may adversely affect our ability to obtain additional capital. The holders of these securities
may be expected to exercise or convert their securities when we are able to obtain additional equity capital on terms more favorable
than these securities.
We
do not intend to pay cash dividends to our stockholders, so you will not receive any return on your investment in our Company
prior to selling your interest in the Company.
The
Company has never paid any cash dividends to our stockholders. We currently intend to retain any future earnings for funding growth
and, therefore, do not expect to pay any cash dividends in the foreseeable future. As a result, you will not receive any return
on your investment prior to selling your shares in our Company, and for the other reasons discussed in this “Risk Factors”
section, you may not receive any return on your investment even when you sell your shares in our Company.
Our
common stock is subject to restrictions on sales by broker-dealers and penny stock rules, which may be detrimental to investors.
Our
common stock is subject to Rules 15g-1 through 15g-9 under the Exchange Act, which imposes certain sales practice requirements
on broker-dealers who sell our common stock to persons other than established customers and “accredited investors”
(as defined in Rule 501(a) of the Securities Act). For transactions covered by this rule, a broker-dealer must make a special
suitability determination for the purchaser and have received the purchaser’s written consent to the transaction prior to
the sale. This rule adversely affects the ability of broker-dealers to sell our common stock and purchasers of our common stock
to sell their shares of our common stock.
6
Additionally,
our common stock is subject to SEC regulations applicable to “penny stocks.” Penny stocks include any non-Nasdaq equity
security that has a market price of less than $5.00 per share, subject to certain exceptions. The regulations require that prior
to any non-exempt buy/sell transaction in a penny stock; a disclosure schedule proscribed by the SEC relating to the penny stock
market must be delivered by a broker-dealer to the purchaser of such penny stock. This disclosure must include the amount of commissions
payable to both the broker-dealer and the registered representative and current price quotations for our common stock. The regulations
also require that monthly statements be sent to holders of a penny stock that disclose recent price information for the penny
stock and information of the limited market for penny stocks. These requirements adversely affect the market liquidity of our
common stock.
Our
Articles of Incorporation allow us to issue preferred stock without shareholder approval.
Our
board of directors has “blank check” authority to issue up to 10,000,000 shares of preferred stock and to determine
the price, rights, preferences, privileges and restrictions, including voting rights, of those shares without any additional vote
or action by our shareholders. The rights of the holders of the common stock will be subject to, and could be materially adversely
affected by, the rights of the holders of any preferred stock that may be issued in the future. For example, we could issue preferred
stock that has superior rights to dividends or is convertible into shares of common stock. This might adversely affect the market
price of the common stock.
If
we experience delays and/or defaults in customer payments, we could be unable to recover all expenditures.
Because
of the nature of our contracts, at times we commit resources to projects prior to receiving payments from the customer in amounts
sufficient to cover expenditures on projects as they are incurred. Delays in customer payments may require us to make a working
capital investment. If a customer defaults in making their payments on a project in which we have devoted resources, it could
have a material negative effect on our working capital and results of operations.
If
we do not effectively manage our growth, our existing infrastructure may become strained, and we may be unable to increase revenue
growth.
Our
past growth that we have experienced, and in the future may experience, may provide challenges to our organization, requiring
us to expand our personnel and our operations. Future growth may strain our infrastructure, operations and other managerial and
operating resources. If our business resources become strained, our earnings may be adversely affected, and we may be unable to
increase revenue growth. Further, we may undertake contractual commitments that exceed our labor resources, which could also adversely
affect our earnings and our ability to increase revenue growth.
The
future issuance of equity or of other securities that are convertible into equity may dilute your investment and reduce your equity
interest.
We
may choose to raise additional capital in the future, depending on market conditions, strategic considerations and operational
requirements. To the extent that additional capital is raised through the issuance of shares of our common stock or other securities
convertible into shares of our common stock, our stockholders’ ownership interests in our Company will be diluted. Future
issuances of our common stock, other equity securities or other securities convertible into shares of our common stock or other
equity securities, the exercise of currently outstanding or future options or warrants for our common stock, or the perception
that such sales or exercises may occur, could adversely affect the prevailing market price of our common stock and impair our
ability to raise capital through future offerings of equity or equity-linked securities.
Our
auditor indicated that certain factors raise substantial doubt about our ability to continue as a going concern.
The
financial statements included with this report are presented under the assumption that we will continue as a going concern, which
contemplates the realization of assets and the satisfaction of liabilities in the normal course of business over a reasonable
length of time. We had a net loss of approximately $7.0 million for the year ended September 30, 2020 and an accumulated
deficit in aggregate of approximately $68.4 million at year end. We are not generating sufficient operating cash flows
to support continuing operations and expect to incur further losses in the development of our business.
In
our financial statements for the year ended September 30, 2020, our auditor indicated that certain factors raised substantial
doubt about our ability to continue as a going concern. These factors included our accumulated deficit, as well as the fact that
we were not generating sufficient cash flows to meet our regular working capital requirements. Our ability to continue as a going
concern is dependent upon our ability to generate future profitable operations and/or to obtain the necessary financing to meet
our obligations and repay our liabilities arising from normal business operations when they come due. Management’s plan
to address our ability to continue as a going concern includes: (1) obtaining debt or equity funding from private placement or
institutional sources; and (2) generating cash flow from operations. Although management believes that it will be able to obtain
the necessary funding to allow us to remain a going concern through the methods discussed above, there can be no assurances that
such methods will prove successful. The accompanying financial statements do not include any adjustments that might result from
the outcome of this uncertainty.
ITEM
1B. UNRESOLVED STAFF COMMENTS
Not
applicable.
ITEM
2. PROPERTIES
We
lease office space at 2107 Wilson Blvd. S#530, Arlington, Virginia. In February 2020, we entered into a lease agreement with our
landlord for approximately 3,666 square feet. The lease was effective February 1, 2020 and has a five year and six months term.
The initial monthly rent is $13,289, and the lease agreement provides for annual rent increases of approximately 2.7%. The amount
of future payments guaranteed is $822,082. We terminated the employment with all of the employees working in the Arlington space
during the restructure completed in April. As such, we have surrendered the space to the landlord and are actively negotiating
an exit from the lease.
ITEM
3. LEGAL PROCEEDINGS
See
“Litigation” in Note 7 – Commitments and Contingencies of the Notes to the Financial Statements in Part II,
Item 8 of this Annual Report on Form 10-K.
ITEM
4. MINE SAFETY DISCLOSURES
Not
applicable.
7
PART
II
ITEM
5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our
common stock is traded on the over-the-counter market and quoted on the OTCQB Venture Market run by OTC Markets Group under the
symbol “CLOK.”
As
of December 23, 2020, there were 27,505,196 shares of common stock of the Company issued and outstanding, and there were
1,121 holders of the Company’s common stock. The actual number of holders of our common stock is greater than this
number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers
or held by other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust
by other entities.
Dividends
We
did not declare any dividends for the year ended September 30, 2020. Our Board of Directors does not intend to declare dividends
in the foreseeable future. The declaration, payment, and amount of any future dividends will be made at the discretion our Board
of Directors, and will depend upon, among other things, the results of our operations, cash flows and financial condition, operating
and capital requirements, and other factors as the Board of Directors considers relevant. There is no assurance that future dividends
will be paid, and if dividends are paid, there is no assurance with respect to the amount of any such dividend.
Transfer
Agent
The
Transfer Agent and Registrar for our common stock is Pacific Stock Transfer Company located in Las Vegas, Nevada.
Recent
Sales of Unregistered Securities
Stock
Issued for Cash
During
the year ended September 30, 2020, there was no stock issued for cash.
Stock
and Stock Options Issued to Board of Directors and Officers
During
the year ended September 30, 2020, the Company issued 620,000 stock options to employees that were subsequently forfeited due
to employee terminations. Stock compensation expense for $194,896 was recognized in the period.
During
the year ended September 30, 2019, the Company issued 9,346 shares of common stock with a fair value of $11,216 to its employees
as part of their compensation. The Company also issued 1,100,000 stock options to members of the board of directors and officers
with a Black Scholes value of $862,000 to vest ratably over a three-year period. Stock compensation expense for $45,942
was recognized in the period.
During
the year ended September 30, 2020, 300,000 stock options were cancelled due to the termination of employment. As of September
30, 2020, 800,000 stock options are outstanding. None of the shares are in the money and the unamortized amount of stock compensation
as of September 30, 2020 is $383,453.
Stock
Issued for Services
During
the year ended September 30,2020, the Company did not issue any stock for services.
During
the year ended September 30, 2019, the Company issued 20,000 shares of common stock with a fair value of $40,000 to a consultant
for consulting services rendered.
The
foregoing offers, sales and issuances were exempt from registration under Section 4(a)(2) of the Securities Act.
ITEM
6. SELECTED FINANCIAL DATA
The
Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as
defined in Rule 229.10(f)(1).
8
ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The
following discussion and analysis should be read in conjunction with our financial statements, including the notes thereto, appearing
elsewhere in this Annual Report on Form 10-K.
Our
Business
We
are developing products and services around our patented polymorphic encryption technology designed to enable a more efficient
and stronger layer of protection to be added to existing solutions. Through a licensing program, we anticipate offering the first
secure commercially viable advanced “Polymorphic Encryption Core” (“PEC”) software developers kit to be
used in any commercial data security industry and/or in sensitive applications.
Our
innovative and patented polymorphic technology eliminates the flaws and inadequacies associated with today’s encryption
algorithms. Instead of dealing with large monolithic blocks of data, our approach decomposes the information to be protected into
multiple segments. These individual segments each have a unique encryption key, utilize different encryption algorithms, are randomly
grouped into different lengths, and can be further re-encrypted. Since segments are independent from each other and are individually
protected, our technology is not susceptible to computational attacks. In fact, the strength of our technology improves as compute
power increases.
Critical
Accounting Policies
Our
financial statements are prepared in accordance with accounting principles generally accepted in the United States of America
(GAAP). The preparation of these financial statements requires the use of estimates and assumptions that affect the reported amounts
of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and the reported
amount of revenues and expenses during the reporting period. Our management periodically evaluates the estimates and judgments
made. Management bases its estimates and judgments on historical experience and on various factors that are believed to be reasonable
under the circumstances. Actual results may differ from these estimates as a result of different assumptions or conditions.
The
methods, estimates, and judgment we use in applying our most critical accounting policies have a significant impact on the results
we report in our financial statements. The SEC has defined “critical accounting policies” as those accounting policies
that are most important to the portrayal of our financial condition and results and require us to make our most difficult and
subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based upon this
definition, our most critical estimates are accounting for convertible debt and embedded derivatives, software revenue recognition,
and stock issued to employees and non-employees. Our most critical accounting policies applicable to the periods presented are
noted below. For additional information see Note 2, “Significant Accounting Policies” in the notes to our financial
statements appearing elsewhere in this report. Although we believe that our estimates and assumptions are reasonable, they are
based upon information presently available, and actual results may differ significantly from these estimates.
Our
critical accounting policies and estimates are those related to revenue recognition, deferred income taxes, accounting for share-based
payments, and litigation.
Revenue
Recognition . We adopted the new accounting revenue standard for revenue recognition effective October 1, 2018 using the modified
retrospective transition method applied to those contracts which were not completed as of October 1, 2018. Results for reporting
periods beginning after October 1, 2018 are presented under this new guidance, while prior period amounts are not adjusted and
continue to be reported in accordance with our historic accounting under previous revenue guidance. See Note (1) Summary of Significant
Accounting Policies.
The
Company’s contracts with customers often include promises to transfer multiple products and services to a customer. Determining
whether products and services are considered distinct performance obligations that should be accounted for separately versus together
may require significant judgment.
9
Judgment
is required to determine the standalone selling price (“SSP”) for each distinct performance obligation. For products
and services aside from maintenance and support, the Company estimates SSP by adjusting the list price by historical discount
percentages. SSP for software and hardware maintenance and support fees is based on the stated percentages of the fees charged
for the respective products.
The
Company’s perpetual and term software licenses have significant standalone functionality and therefore revenue allocated
to these performance obligations are recognized at a point in time upon electronic delivery of the download link and the license
keys. For certain arrangements revenue is recognized based on usage or ratably over the term of the arrangement.
Product
maintenance and support services are satisfied over time as they are stand-ready obligations throughout the support period. As
a result, revenues associated with maintenance services are deferred and recognized as revenue ratably over the term of the contract.
Revenues
associated with professional services are recognized at a point in time upon customer acceptance.
Accounting
for Share-Based Payments . As discussed further in Note (10) Share-Based Payment Arrangements , to our consolidated financial
statements, we account for share-based awards in accordance with the authoritative guidance issued by the FASB on stock compensation.
We
have used and expect to continue to use the Black-Scholes option-pricing model to compute the estimated fair value of share-based
compensation expense. The Black-Scholes option-pricing model includes assumptions regarding dividend yields, expected volatility,
expected option term and risk-free interest rates. The assumptions used in computing the fair value of share-based compensation
expense reflect our best estimates, but involve uncertainties relating to market and other conditions, many of which are outside
of our control. We estimate expected volatility based primarily on historical daily price changes of our stock and other factors.
The expected option term is the number of years that we estimate that the stock options will be outstanding prior to exercise.
The estimated expected term of the stock awards issued has been determined pursuant to SEC Staff Accounting Bulletin SAB No. 110.
If other assumptions or estimates had been used, the share-based compensation expense that was recorded for the years ended September
30, 2019 and 2018 could have been materially different. Furthermore, if different assumptions or estimates are used in future
periods, share-based compensation expense could be materially impacted in the future.
Under
ASC 718-20-35-7, Repurchase or Cancellation of equity awards, the amount of cash or other assets transferred (or liabilities incurred)
to repurchase an equity award shall be charged to equity, to the extent that the amount paid does not exceed the fair value of
the equity instruments repurchased at the repurchase date. Any excess of the repurchase price over the fair value of the instruments
repurchased shall be recognized as additional compensation cost.
10
Results
of Operations
Fiscal
Year Ended September 30, 2020 Compared to Fiscal Year Ended September 30, 2019
Revenue
increased to $47,983 for the year ended September 30, 2020 from $46,600 for the year ended September 30, 2019. There was no cost
of revenues for the years ended September 30, 2020 or September 30, 2019.
General
and administrative expenses increased to $4,573,673 for the year ended September 30, 2020 from $3,372,047 for the year ended September
30, 2019. The increases in general and administrative expenses primarily resulted from higher legal expenses of $1,043,820, an
impairment loss related to the operating leases of $382,962, increase in stock compensation of $153,355 , an increase in
corporate insurance of $142,197 and an increase in salary expense of $101,099 offset by decrease in payroll taxes of $236,369
along with, the decrease in miscellaneous expense over last year that included payments totaling $416,000 to Quality Healthcare
International, Inc. (“QHI”) and Noun Energy.
Sales
and marketing expenses decreased to $710,595 for the year ended September 30, 2020 from $1,772,197 for the year ended September
30, 2019. Sales and marketing expenses decreased primarily due to non-recurring payments made to Ageos during 2019 to hire individual
sales consultants under contract with the Company for $1,217,072 and a decrease in travel related costs of $49,559 offset by an
increase in salary expense of $205,029.
Research
and development expenses decreased to $1,689,455 for the year ended September 30, 2020 from $1,744,480 for the year ended September
30, 2019. Research and development expenses decreased primarily as a result lower salary expense of $604,489, a decrease in stock
compensation of $15,615 offset by an increase in consulting expense of $565,079
Total
other expenses, net, increased to $44,332 for the year ended September 30, 2020 from $8,101 for the year ended September 30, 2019.
The increase is a result of losses on the disposal of fixed assets.
Liquidity
and Capital Resources
We
had an accumulated deficit as of September 30, 2020 of $68,426,608. We expect to generate continued operating losses until
we generate revenues sufficient to exceed our operating expenses. At September 30, 2020, we had $1,079,839 in cash. We do not
believe that our existing cash balances are sufficient to fund future operations for the next 12 months. We are considering options
to issue additional equity as a means to increase liquidity sufficient to fund operations through December 31, 2021.
11
Cash
Flows
The
following table summarizes, for the periods indicated, selected items in our Statements of Cash Flows:
Year
Ended September 30,
2020
2019
Net cash (used in) provided by:
Operating
activities
$
(6,646,091
)
$
(6,139,815
)
Investing activities
$
(28,972
)
$
(37,059
)
Financing activities
$
(84,570
)
$
(40,000
)
Operating
Activities
For the year ended September 30, 2020, cash
used in operating activities was $6,646,091, primarily attributable to a net loss of $6,970,072 non-cash items of $640,433
and a net change in net operating assets and liabilities of $316,452. Non-cash items primarily consisted of an impairment
loss of $382,961 related to operating leases, stock compensation expense of $194,896, a net loss on disposal of assets of $44,332
and depreciation of $18,243. The change in our net operating assets and liabilities was primarily due to an increase in prepaid
and other assets of $322,912 and an increase in accounts payable and accrued liabilities of $6,460. The Company used cash
during the year to pay for the cost of general and administrative, sales and marketing, and research and development activities
which combined to be $6,973,723.
For
the year ended September 30, 2019, cash used in operating activities was $6,139,815, primarily attributable to a net loss of $6,834,023,
partially offset by the net change in our net operating assets and liabilities of $580,123 and non-cash charges of $114,085. The
change in our net operating assets and liabilities was primarily due to an increase in prepaid expenses and other assets of $116,719
and an increase in accounts payable and accrued liabilities of $696,842. Non-cash charges consisted of stock compensation of $57,158,
shares issued in exchange for services of $40,000 and depreciation of $16,927.
Investing
Activities
Cash
used in investing activities was $28,972 and $37,059, attributable to the purchases of property and equipment for the years ended
September 30, 2020 and 2019, respectively.
Financing
Activities
For
the year ended September 30, 2020, cash provided by financing activities was $215,430, primarily derived from the proceeds from
the PPA loan of $365,430, offset by a payment of $450,000 for the repurchase of treasury stock.
For
the years ended September 30, 2019, cash used in financing activities was $40,000, was due to a payout related to an oversubscription
on a capital raise.
Off-Balance
Sheet Arrangements
We
did not have during the periods presented, nor do we currently have, any off-balance sheet arrangements as defined under applicable
SEC rules.
ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The
Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as
defined in Rule 229.10(f)(1).
12
ITEM
8. FINANCIAL STATEMENTS
CIPHERLOC
CORPORATION
TABLE
OF CONTENTS
Page
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
14
FINANCIAL
STATEMENTS:
Balance
Sheets as of September 30, 2020 and 2019
15
Statements
of Operations for the years ended September 30, 2020 and 2019
16
Statements
of Stockholders’ Equity (Deficit) for the years ended September 30, 2020 and 2019
17
Statements
of Cash Flows for the years ended September 30, 2020 and 2019
18
NOTES
TO FINANCIAL STATEMENTS
19
13
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the Board of Directors and
Stockholders
of Cipherloc Corporation
Opinion
on the Financial Statements
We
have audited the accompanying balance sheets of Cipherloc Corporation (the “Company”) as of September 30, 2020 and
2019, and the related statements of operations, stockholders’ equity (deficit), and cash flows for each of the years in
the two-year period ended September 30, 2020, and the related notes (collectively referred to as the “financial statements”).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of
September 30, 2020 and 2019, and the results of its operations and its cash flows for each of the years in the two-year period
ended, in conformity with accounting principles generally accepted in the United States of America.
The
Company’s Ability to Continue as a Going Concern
The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 2 to the financial statements, the Company has incurred recurring losses from its operations, has negative working capital,
and a significant accumulated deficit, which raise substantial doubt about its ability to continue as a going concern. Management’s
plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
Basis
for Opinion
These
financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on
the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.
We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but
not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.
Accordingly, we express no such opinion.
Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audits provide a reasonable basis for our opinion.
/s/
Briggs & Veselka Co.
We
have served as the Company’s auditor since 2019.
Houston,
Texas
December
28, 2020
14
CIPHERLOC
CORPORATION
BALANCE
SHEETS
September
30,
2020
September
30,
2019
ASSETS
Current assets
Cash
$
1,079,839
$
7,839,472
Prepaid
expenses
258,424
121,371
Total
current assets
1,338,263
7,960,843
Other assets
200,000
7,566
Operating lease ROU
asset
291,140
—
Fixed
assets, net
—
40,182
Total
assets
$
1,829,403
$
8,008,591
LIABILITIES &
STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable
and accrued liabilities
$
840,234
$
650,681
Accrued compensation
10,000
142,293
Operating lease liability
– current portion
132,608
—
Paycheck
protection program loan – current portion
216,902
—
Deferred
revenue
15,417
28,400
Total
current liabilities
1,215,161
821,374
Paycheck protection
program loan – long term
148,528
—
Operating lease
liability – long-term portion
603,676
—
Total
liabilities
1,967,365
821,374
Commitments and contingencies
Series A convertible preferred stock, $0.01
par value, 1,000,000 shares authorized; 1,000,000 shares issued and outstanding as of September 30, 2020 and September 30,
2019
10,000
10,000
Common stock, $0.01 par value, 681,000,000 shares
authorized; 27,505,196 and 40,792,510 shares outstanding; and 40,792,510 and 40,792,510 issued as of September 30, 2020 and
September 30, 2019, respectively
407,925
407,925
Treasury stock, at cost 13,287,314 shares
(550,000
)
—
Additional paid-in capital
68,420,721
68,225,828
Accumulated deficit
(68,426,608
)
(61,456,536
)
Total
stockholders’ equity (deficit)
(137,962
)
7,187,217
Total
liabilities and stockholders’ equity (deficit)
$
1,829,403
$
8,008,591
The
accompanying notes are an integral part of these financial statements.
15
CIPHERLOC
CORPORATION
STATEMENTS
OF OPERATIONS
For
the Year Ended
September
30,
2020
2019
Revenues
$
47,983
$
46,600
Cost of revenues
—
—
Gross profit
47,983
46,600
Operating expenses:
General and administrative
4,573,673
3,372,047
Sales and marketing
710,595
1,772,197
Research
and development
1,689,455
1,744,480
Total
operating expenses
6,973,723
6,888,724
Operating loss
(6,925,740
)
(6,842,124
)
Other (expenses) income:
Loss
on disposal of asset
(44,332)
—
Interest
income, net
—
8,101
Total
other income, net
(44,332
)
8,101
Net loss
$
(6,970,072
)
$
(6,834,023
)
Net loss per common
share - Basic and diluted:
$
(0.18
)
$
(0.17
)
Weighted average
common shares outstanding - Basic and diluted
39,495,185
40,792,510
The
accompanying notes are an integral part of these financial statements.
16
CIPHERLOC
CORPORATION
STATEMENTS
OF STOCKHOLDERS’ EQUITY
FOR
THE YEARS ENDED SEPTEMBER 30, 2020 AND 2019
Preferred
Stock
Common
Stock
Additional
Stockholders’
Shares
Amount
Shares
Issued
Amount
Treasury
Stock
Paid-in
Capital
Accumulated
Deficit
Equity
(Deficit)
Balance at, September 30,
2018
1,000,000
$ 10,000
40,743,917
$ 407,438
$ 0
$ 68,169,157
$ (54,622,513 )
$ 13,964,082
Common stock issued to an employee
—
—
9,346
94
11,122
—
11,216
Stock option expense issued to directors
and officers
—
—
—
—
45,942
—
45,942
Common stock issued for services
—
—
20,000
200
39,800
—
40,000
Correction of shares outstanding
—
—
19,247
193
(193 )
—
—
Refund of oversubscription
—
—
—
—
(40,000 )
—
(40,000
Net loss
—
—
—
—
—
(6,834,023 )
(6,834,023 )
Balance at September
30, 2019
1,000,000
$ 10,000
40,792,510
$ 407,925
$ 0
$ 68,225,825
$ (61,456,536 )
$ 7,187,217
Stock option expense issued to directors
and officers
—
—
—
—
194,896
—
194,896
Purchase of treasury stock
—
—
—
—
$ (550,000 )
—
—
$ (550,000 )
Net loss
—
—
—
—
—
(6,970,072 )
(6,970,072 )
Balance at September
30, 2020
1,000,000
$ 10,000
40,792,510
$ 407,925
$ (550,000 )
$ 68,420,721
$ (68,426,608 )
$ (137,962 )
The
accompanying notes are an integral part of these financial statements.
17
CIPHERLOC
CORPORATION
STATEMENTS
OF CASH FLOWS
For
the Year Ended
September
30,
2020
2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
$
(6,970,072
)
$
(6,834,023
)
Adjustments to reconcile
net loss to net cash used in operating activities:
Depreciation
18,243
16,927
Stock-based compensation
194,896
57,158
Impairment loss
382,961
—
Loss on disposal
of asset
44,333
—
Stock issued for
services
—
40,000
Changes in operating
assets and liabilities:
Prepaid expenses
and other assets
(322,912
)
(116,719
)
Accounts payable
and accrued liabilities
1 51,736
598,638
Accrued compensation
(132,293
)
69,804
Deferred
revenue
(12,983
)
28,400
Net
cash used in operating activities
(6,646,091
)
(6,139,815
)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase
of fixed assets
(28,972
)
(37,059
)
Net
cash used in investing activities
(28,972
)
(37,059
)
CASH FLOWS FROM FINANCING ACTIVITIES
Purchase of treasury
stock
(450,000
)
—
Proceeds from PPP loan
365,430
—
Repayment
of oversubscription
—
(40,000
)
Net
cash provided by (used in) financing activities
(84,570
)
(40,000
)
DECREASE IN CASH
(6,759,633
)
(6,216,874
)
CASH, BEGINNING
OF YEAR
7,839,472
14,056,346
CASH, END OF YEAR
$
1,079,839
$
7,839,472
NON-CASH INVESTING AND FINANCING ACTIVITIES :
Capitalization
of ROU asset
$
746,125
$
—
ST
operating lease liability recorded
$
61,264
$
—
LT
operating lease liability recorded
$
684,861
$
—
Unpaid treasury stock
$
100,000
—
The
accompanying notes are an integral part of these financial statements.
18
CIPHERLOC
CORPORATION
NOTES
TO FINANCIAL STATEMENTS
FOR
THE YEARS ENDED SEPTEMBER 30, 2020 AND 2019
NOTE
1 - DESCRIPTION OF BUSINESS
Cipherloc
Corporation (the “Company” or “Cipherloc”) was incorporated in the State of Texas on June 22, 1953 as
American Mortgage Company. Effective August 27, 2014, the Company changed its name to Cipherloc Corporation.
NOTE
2 - GOING CONCERN
We
do not believe that our existing cash balances are sufficient to fund future operations for the next 12 months. We are considering
options to issue additional equity as a means to increase liquidity sufficient to fund operations into the start of calendar year
2022. If we are unsuccessful doing so, then the Company will cease operations.
At
September 30, 2020, the Company had not yet achieved profitable operations. We had a net loss of approximately $7.0 million
for the year ended September 30, 2020 and had an accumulated deficit in aggregate of approximately $68.4 million since
our inception. We expect to incur further losses in the development of our business. These conditions raise substantial doubt
about the Company’s ability to continue as a going concern.
The
Company’s ability to continue as a going concern is dependent on its ability to generate future profitable operations and/or
to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when
they come due. Management’s plan to address the Company’s ability to continue as a going concern includes: (1) obtaining
debt or equity funding from private placement or institutional sources; (2) generating cash flow from operations. Although management
believes that it will be able to obtain the necessary funding to allow the Company to remain a going concern through the methods
discussed above, there can be no assurances that such methods will prove successful.
These
financial statements have been prepared assuming that the Company will continue as a going concern and therefore, the financial
statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets
or the amount and classifications of liabilities that may result from the outcome of this uncertainty.
NOTE
3 – SIGNIFICANT ACCOUNTING POLICIES
The
Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of
America (“U.S. GAAP”). Significant accounting policies are as follows:
Use
of Estimates and Assumptions
The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect
(i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as
of the date the financial statements are published, and (iii) the reported amount of net revenues and expenses recognized during
the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously
available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of financial statements;
accordingly, actual results could differ from these estimates. The Company’s most significant estimate relates to the valuation
of its convertible note.
Legal
The
Company is subject to legal proceedings, claims and liabilities which arise in the ordinary course of business. The Company accrues
for losses associated with legal claims when such losses are probable and can be reasonably estimated. These accruals are adjusted
as additional information becomes available or circumstances change. Legal fees are charged to expense as they are incurred.
Cash
and Cash Equivalents and Concentration of Credit Risk
The
Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. The
Company did not have any cash equivalents as of September 30, 2020 and 2019. At September 30, 2020 and 2019, cash includes cash
on hand and cash in the bank. The Company maintains its cash in accounts held by large, globally recognized banks which, at times,
may exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation (FDIC). The FDIC insures these
deposits up to $250,000. As of September 30, 2020, $829,839 of the Company’s cash balance was uninsured. The Company has
not experienced any losses on cash.
Fixed
Assets
Fixed
assets are recorded at cost and depreciation is provided over the estimated useful lives of the related assets using the straight-line
method for financial statement purposes. Equipment and furniture are depreciated over an estimated useful life of three (3) to
five (5) years. Leasehold improvements are depreciated over the lesser of the related lease term or a useful life of ten (10)
years. Software is depreciated over an estimated useful life of three (3) years.
Long-Lived
Assets
Long-lived
assets are evaluated for impairment whenever events or changes in business circumstances indicate that the carrying amount of
the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test
is based on a comparison of the undiscounted future cash flows to the recorded value of the asset. If impairment is indicated,
the asset is written down to its estimated fair value. There was no impairment recorded during the year ended September 30, 2019.
During the year ended September 30, 2020, the Company recorded an impairment loss of $382,961 related to its Virginia lease. In
addition, the Company recorded a loss of $44,336 on the disposal of fixed assets.
19
Fair
Value of Financial Instruments
The
Company’s financial instruments consisted primarily of cash, accounts payable and accrued expenses, deferred revenue, convertible
note payable, as well as embedded conversion features. The carrying amounts of such financial instruments approximate their respective
estimated fair value due to the short-term maturities and approximate market interest rates of these instruments.
Fair
value is focused on an exit price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. Within the measurement of fair value, the use of market-based information
is prioritized over entity specific information and a three-level hierarchy for fair value measurements is used based on the nature
of inputs used in the valuation of an asset or liability as of the measurement date.
The
three-level hierarchy for fair value measurements is defined as follows:
●
Level
1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active
markets;
●
Level
2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets,
and inputs that are observable for the asset or liability other than quoted prices, either directly or indirectly, including
inputs in markets that are not considered to be active;
●
Level
3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.
The
fair values of the embedded conversion features in the Company’s convertible notes and of the warrants issued by the Company
were determined using level 2 measurements and are discussed in further detail in Notes 5 and 8, respectively.
Customer
Concentration
During
the year ended September 30, 2020 two customers accounted for approximately 100% of the Company’s revenues. During the year
ended September 30, 2019, one customer accounted for approximately 100% of the Company’s revenues.
20
Revenue
Recognition
The
Company recognizes revenues in accordance with the provisions of Accounting Standards Update 2014-09, “Revenue from Contracts
with Customers,” and a series of amendments which together we identify as “ASC Topic 606”. This new accounting
standard, which we adopted on October 1, 2018 using the permitted modified retrospective method, outlines a single comprehensive
model for entities to use in accounting for revenues arising from contracts with customers. The new standard supersedes most previous
revenue recognition guidance, including industry-specific guidance. The effect of the adoption of ASC Topic 606 on retained earnings
as of October 1, 2018 was not material. The differences between our reported operating results for the nine months ended June
30, 2020, which reflect the application of the new standard on our contracts, and the results that would have been reported if
the accounting was performed pursuant to the accounting standards previously in effect, also were not material.
Central
to the new revenue recognition guidance is a five-step revenue recognition model that requires reporting entities to:
1.
Identify the contract,
2.
Identify the performance obligations of the contract,
3.
Determine the transaction price of the contract,
4.
Allocate the transaction price to the performance obligations, and
5.
Recognize revenue.
The
Company accounts for a promise to provide a customer with a right to access the Company’s intellectual property as a performance
obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s
performance of providing access to its intellectual property as the performance occurs.
Nature
of Products and Services
Licenses
for on-premises software provide the customer with a right to use the software as it exists when made available to the customer.
Customers may purchase perpetual licenses or subscribe to licenses, which provide customers with the same functionality and differ
mainly in the duration over which the customer benefits from the software. Revenue from distinct on-premises licenses is recognized
upfront at the point in time when the software is made available to the customer. In cases where the license is being modified
at the direction of the customer the revenue is being recognized ratably over the term of the arrangement. Revenue allocated to
software maintenance and support services is recognized ratably over the contractual support period.
Professional
services are primarily related to software implementation services and associated revenue is recognized upon customer acceptance.
Contract
Balances
Timing
of revenue recognition may differ from the timing of invoicing to customers. The Company records a contract asset or receivable
when revenue is recognized prior to invoicing, or unearned revenue when revenue is recognized subsequent to invoicing. For perpetual
licenses with multi-year product maintenance agreements, the Company generally invoices customers at the beginning of the coverage
period. For multi-year subscription licenses, the Company generally invoices customers annually at the beginning of each annual
coverage period. The Company records a contract asset related to revenue recognized for multi-year on-premises licenses as its
right to payment is conditioned upon providing product support and services in future years.
There
were no accounts receivable balances on September 30, 2020 and 2019. There was no adjustment needed to the accounts receivable
for the cumulative effect of applying ASC 606 under the modified retrospective method. There was no impact on the opening balance
contract assets and liabilities, for the cumulative effect of applying ASC 606 under the modified retrospective method as of October
1, 2018.
Deferred
revenue is comprised mainly of unearned revenue related maintenance and technical support on term and perpetual licenses. Maintenance
and technical support revenue are recognized ratably over the coverage period. Deferred revenue also includes contracts for professional
services to be performed in the future which are recognized as revenue when the company delivers the related service pursuant
to the terms of the customer arrangement.
21
Changes
in deferred revenue were as follows:
Year Ended September 30, 2019
Balance on September 30, 2018
$ —
Cumulative effect
of applying ASC 606 under the modified retrospective method*
—
Deferral of revenue
75,000
Recognition
of revenue
(46,600 )
Balance at September 30, 2019
$ 28,400
Year Ended September 30, 2020
Balance on September 30, 2019
$ 28,400
Deferral of revenue
35,000
Recognition
of revenue
(47,983 )
Balance at September 30, 2020
$ 15,417
*See
Note (1) Summary of Significant Accounting Policies, section (s) to our Financial Statements for further information.
Deferred
revenue includes invoiced revenue allocated to remaining performance obligations that has not yet been recognized and will be
recognized as revenue in future periods. Deferred revenue was $15,417 as of September 30, 2020, of which the Company expects to
recognize 100% of the revenue over the next 12 months.
Payment
terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 90 days. In
instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts
generally do not include a significant financing component. The primary purpose of the Company’s invoicing terms is to provide
customers with simplified and predictable ways of purchasing its products and services, not to receive financing from our customers
or to provide customers with financing. Examples include invoicing at the beginning of a subscription term with maintenance and
support revenue recognized ratably over the contract period, and multi-year on-premises licenses that are invoiced annually with
product revenue recognized upon delivery.
Significant
Judgments
The
Company’s contracts with customers often include promises to transfer multiple products and services to a customer. Determining
whether products and services are considered distinct performance obligations that should be accounted for separately versus together
may require significant judgment.
Judgment
is required to determine the standalone selling price (“SSP”) for each distinct performance obligation. For products
and services aside from maintenance and support, the Company estimates SSP by adjusting the list price by historical discount
percentages. SSP for software and hardware maintenance and support fees is based on the stated percentages of the fees charged
for the respective products. The Company’s perpetual and term software licenses may have significant standalone functionality
and therefore revenue allocated to these performance obligations are recognized at a point in time upon electronic delivery of
the download link and the license keys. In cases where the license is being modified at the direction of the customer the revenue
is being recognized ratably over the term of the arrangement. Product maintenance and support services are satisfied over time
as they are stand-ready obligations throughout the support period. As a result, revenues associated with maintenance services
are deferred and recognized as revenue ratably over the term of the contract.
Revenues
associated with professional services are recognized at a point in time upon customer acceptance.
Assets
Recognized from Costs to Obtain a Contract with a Customer
The
Company recognizes an asset for the incremental costs of obtaining a contract with a customer if it expects the benefit of those
costs to be longer than one year. The Company has determined that its sales commission program meets the requirements for cost
capitalization. Total capitalized costs to obtain a contract were immaterial during the periods presented. The Company applies
a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period
would have been one year or less.
Software
license revenue is generally recognized when a signed contract or other persuasive evidence of an arrangement exists, the software
has been electronically delivered, the license fee is fixed or is measured on a paid user basis, and collection of the resulting
receivable is probable. When contracts contain multiple elements wherein Vendor-Specific Objective Evidence (“VSOE”)
exists for all undelivered elements, we account for the delivered elements in accordance with the “Residual Method.”
VSOE of fair value for maintenance and support is established by a stated renewal rate, if substantive, included in the license
arrangement or rates charged in stand-alone sales of maintenance and support. Revenue from subscription license agreements, which
include software, rights to unspecified future products and maintenance, is recognized ratably over the term of the subscription
period. When the fair value of VSOE of post contract customer support cannot be determined, the revenue is recognized ratably
over the contract period. The only remaining undelivered element was post contract support services, and accordingly, the revenues
were recognized on a pro rata basis prospectively over the terms of the related contracts. Deferred revenue results from fees
billed to or collected from customers for which revenue has not yet been recognized.
The
Company had deferred revenue of $15,417 and $28,400 as of September 30, 2020 and 2019, respectively.
22
Research
and Development and Software Development Costs
The
Company expenses all research and development costs, including patent and software development costs. Our research and development
costs incurred for the years ended September 30, 2020 and 2019 were $1,689,455 and $1,744,480, respectively.
Stock-Based
Compensation
The
Company measures the cost of services provided by employees and non-employees in exchange for an award of an equity instrument
based on the grant-date fair value of the award. There were stock options issued during the year ended September 30, 2020, however,
awards were subsequently forfeited. Outstanding awards are the awards issued for the fiscal year 2019. There were both fully vested
stock grants and stock options granted to employees and non-employees during the year ended September 30, 2019. As such, compensation
cost was recognized for grant as well as a ratable portion for the stock options vesting over a three-year time frame.
The
Company accounts for share-based payments in accordance with the authoritative guidance issued by the FASB on share-based compensation,
which establishes the accounting for transactions in which an entity exchanges its equity instruments for goods or services. Under
the provisions of the authoritative guidance, share-based compensation expense is measured at the grant date, based on the fair
value of the award, and is recognized as an expense over the requisite employee service period (generally the vesting period),
net of actual forfeitures. The Company estimates the fair value of share-based payments using the Black-Scholes option-pricing
model. Additionally, share-based awards to non-employees are expensed over the period in which the related services are rendered
at their fair value. All share-based awards are expected to be fulfilled with new shares of common stock.
Under
ASC 718-20-35-7, Repurchase or Cancellation of equity awards, the amount of cash or other assets transferred (or liabilities incurred)
to repurchase an equity award shall be charged to equity, to the extent that the amount paid does not exceed the fair value of
the equity instruments repurchased at the repurchase date. Any excess of the repurchase price over the fair value of the instruments
repurchased shall be recognized as additional compensation cost.
Income
Taxes
The
Company utilizes the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities
are recognized for operating loss and tax credit carryforwards and for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax
assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates
is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to
reduce the carrying amounts of deferred tax assets unless it is more likely than not that the value of such assets will be realized.
The
Company uses the two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position
for recognition by determining if the weight of available evidence indicates it is more likely than not, that the position will
be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure
the tax benefit as the largest amount, which is more than 50% likely of being realized upon ultimate settlement. The Company considers
many factors when evaluating and estimating the Company’s tax positions and tax benefits, which may require periodic adjustments.
The Company did not record any liabilities for uncertain tax positions during the years ended September 30, 2020 or 2019.
23
Basic
and Diluted Net Loss per Common Share
Basic
loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares
outstanding during the reporting period. The weighted average number of shares is calculated by taking the number of shares outstanding
and weighting them by the amount of time that they were outstanding. Diluted earnings per share reflects the potential dilution
that could occur if stock options, warrants, and other commitments to issue common stock were exercised or equity awards vest
resulting in the issuance of common stock that could share in the earnings of the Company. As of September 30, 2020, and 2019,
the Company had 1,000,000 shares of preferred stock outstanding, which are convertible into 1,500,000 shares of common stock.
Diluted
loss per share is the same as basic loss per share during periods where net losses are incurred since the inclusion of the potential
common stock equivalents would be anti-dilutive as a result of the net loss. During the year ended September 30, 2020, 24,146,866
warrants, 800,000 stock options and 1,000,000 shares of convertible preferred stock were excluded from the calculation of diluted
loss per share because their effect would be anti-dilutive. During the year ended September 30, 2019, 24,290,866 warrants, 1,100,000
stock options, and 1,000,000 shares of convertible preferred stock were excluded from the calculation of diluted loss per share
because their effect would be anti-dilutive.
Recent
Accounting Announcements
The
Financial Accounting Standards Board (“FASB”) issues Accounting Standards Updates (“ASU”) to amend the
authoritative literature in the ASC. There have been several ASUs to date that amend the original text of the ASCs. Other than
those discussed below, the Company believes those ASUs issued to date either (i) provide supplemental guidance, (ii) are technical
corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.
In
December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This
guidance removes certain exceptions to the general principles in Topic 740 and enhances and simplifies various aspects of the
income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is
not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. This
standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. Early
adoption is permitted. The Company are currently evaluating the impact of ASU 2019-12 on its financial statements, which is effective
for the Company in its fiscal year and interim periods beginning on October 1, 2021.
In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurements (Topic 820) – Disclosure Framework – Changes
to the Disclosure Requirements for Fair Value Measurement , to modify the disclosure requirements for fair value measurements.
The ASU removes certain disclosure requirements related to transfers between fair value hierarchy levels and valuation processes
for Level 3 fair value measurements. It modifies certain disclosure requirements for investments in entities that calculate net
asset value. It adds certain disclosure requirements regarding gains and losses for recurring Level 3 fair value measurements
and unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for fiscal years, and interim
periods within those fiscal years, beginning after December 15, 2019. The Company adopted ASU 2018-13 on October 1, 2019 and the
adoption of this update did not have a material impact on the Company’s notes to the financial statements.
In
June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718) – Improvements to Nonemployee
Share-Based Payment Accounting , to expand the scope of Topic 718, Compensation – Stock Compensation , which currently
only includes share-based payments to employees, to include share-based payments issued to nonemployees for goods or services.
Thus, accounting for share-based payments to nonemployees and employees will be substantially aligned. ASU 2018-07 is effective
for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The Company adopted ASU 2018-07
on October 1, 2019 and the adoption of this update did not have a material impact on the Company’s financial position, results
of operations and cash flows.
In
February 2016, the FASB issued ASU 2016-02, Leases, which aims to make leasing activities more transparent and comparable and
requires substantially all leases be recognized by lessees on their balance sheet as a right-of-use asset (ROU) and corresponding
lease liability, including leases currently accounted for as operating leases. Leases of mineral reserves and related land leases
have been exempted from the standard. We adopted ASU 2016-02, Leases, on October 1, 2019. We elected the “package of practical
expedients” within the standard which permits us not to reassess prior conclusions about lease identification, lease classification
and initial direct costs. We made an accounting policy election to not separate lease and non-lease components for all leases.
The adoption of this standard resulted in the recognition of right-of-use assets and lease liabilities of $0.2 million, which
were not previously recorded on our balance sheet.
24
NOTE
4 – FIXED ASSETS, NET
As
of September 30, 2020, and 2019, fixed assets consisted of the following:
September
30,
2020
2019
Equipment and furniture
$ —
$ 37,875
Leasehold improvements
—
17,630
Software
—
12,676
—
68,181
Accumulated depreciation
—
(27,999 )
Fixed
assets, net
$ —
$ 40,182
Depreciation
expense for the years ended September 30, 2020 and 2019 was $18,243 and $16,927, respectively. The fixed assets were disposed
of during 2020.
NOTE
5 – SOFTWARE LICENSES
Software
License Agreements
During
fiscal year 2019, the Company entered into a one-year agreement with SoundFi LLC (“SoundFi”) which will automatically
renew for subsequent one-year periods unless otherwise terminated by either party. Cipherloc received $25,000 from SoundFi during
the year ended September 30, 2020.
The
Company executed an annual software licensing agreement with Castle Shield during the year ended September 30, 2020 which
also include auto-renewing terms. Castle Shield made a $10,000 payment to the Company based on the terms of their agreement with
Cipherloc.
During
the year ended September 30, 2020, the Company recognized $47,983 in licensing revenue from the SoundFi and Castle Shield agreements.
25
NOTE
6 – DEBT
On
April 6, 2020, to supplement its cash balance, the Company submitted their application for a Paycheck Protection Program (“PPP”)
loan (the “SBA loan”) sponsored by the U.S. Small Business Administration in the amount of $365,430. On April 12,
2020, Company’s SBA loan application was approved, and the Company received loan proceeds on April 22, 2020. The SBA loan
has an interest rate of 1% and matures on April 12, 2022.
Section
1106 of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) provides for forgiveness of up to the
full principal amount of qualifying loans guaranteed under the PPP. The PPP and loan forgiveness are intended to provide economic
relief to small businesses, such as the Company, that are adversely impacted under the COVID-19 Emergency Declaration issued by
President Donald J. Trump on March 13, 2020.
As
a result of staff reductions during 2020, the Company expects the ultimate amount of loan forgiveness to be minimal.
The
Paycheck Protection Program loan balance at September 30, 2020 was $365,430
Future Minimum Paycheck
Protection Program loan payment by Fiscal Year
2021
$ 216,902
2022
148,528
Total Paycheck
Protection Program loan
$ 365,430
NOTE
7 – RELATED PARTY TRANSACTIONS
Employees
related to Ex Chief Executive Officer
Skylar,
Olivia and Robin De La Garza, immediate family members of former CEO Michael De La Garza, earned $52,278, $47,176 and $53,000,
respectively, in compensation for the year ended September 30, 2019. In August 2019, Robin and Skylar De La Garza were terminated
as employees of the Company. The Company also paid $11,394 in educational costs of Skylar De La Garza and $6,200 in moving expenses
of Olivia De La Garza. Michael De La Garza was the CEO and director of the Company during the period of time when these payments
were made.
See
Note 8 for additional related party transactions.
NOTE
8 – COMMITMENTS AND CONTINGENCIES
Litigation
The
Company is currently not involved in any litigation that it believes could have a material adverse effect on its financial condition
or results of operations.
A
disgruntled former consultant has brought an action in Texas state court against the Company and its former chief executive officer,
alleging fraud and misrepresentation pertaining to stock and payments alleged to be owed to the consultant. The Company believes
it has made all required payments and delivered the stock to the consultant. The consultant has also included a claim of partial
ownership of certain of the Company’s patents, which management believes is without merit. The case is currently being defended
by the Company and costs relating thereto have been submitted to the Company’s insurance carrier.
In
August 2019, the Board of Directors formed a special committee of independent directors (the “Special Committee”)
to investigate certain activities of Michael De La Garza (“De La Garza”), our former chief executive officer. Also
in that same month, the Company initiated litigation against De La Garza in the District Court of Travis Country, Texas (the “Court”).
On September 25, 2019, the Court entered a temporary injunction against De La Garza enjoining him from numerous acts. The Special
Committee investigated certain activities of De La Garza, including the Ageos, LLC Operating Agreement, the QHCI/Noun note receivable,
an advance/bonus, personal expenditures, and other items. All amounts expended have been expensed as of September 30, 2019.
The
Company also sued De La Garza, among others, in federal district court seeking to invalidate the issuance of preferred stock to
him in 2015. The preferred stock shares were converted to 13.5 million shares of common stock by De La Garza during 2018.
All
litigation matters with Michael De La Garza were settled on August 28, 2020 with De La Garza agreeing to return 13.1 million shares
of common stock to the Company and the Company agreeing to pay De La Garza $400,000 between September 30, 2020 and September 30,
2021. At September 20, 2020, Cipherloc owed $100,000 in settlement payments which will be made in $25,000 payments on December
1, 2020, March 1, 2021, June 1, 2021, and September 1, 2021.
26
The
Company is seeking to invalidate the issuance of 1 million shares of Cipherloc preferred stock to former director and chief financial
officer, Pamela Thompson, which stock is now being held by the Carmel Trust II, in or around 2011. As such, the Company has sued
James LeGanke, as Trustee of Carmel Trust II, in federal court as part of its efforts to invalidate those shares. The Company
alleges that Thompson failed to comply with both state law and Company bylaws when she and then CEO, Michael De La Garza, caused
the Company to issue the preferred stock to themselves as purported compensation. The lawsuit is ongoing, and its resolution is
unknown.
On
October 13, 2020, Ageos, LLC, a Virginia limited liability company (“Ageos”), filed a Third Party Complaint against
Cipherloc (Third Party Case No. GV20015643-00) in connection with the pending action titled Scandium, LLC v. Ageos, LLC (Case
No. GV20014313-00) in the General District Court for Fairfax County in the Commonwealth of Virginia. The action relates to an
operating agreement, by and between Cipherloc and Ageos, whereby Cipherloc agreed to guarantee Ageos’s lease in order to
enable the leasing of space in Fairfax County, VA. Cipherloc subsequently terminated the agreement with Ageos and offered to take
over the space as an accommodation. Ageos declined. Ageos’s third party complaint demands from Cipherloc, among other things,
all damages obtained by Scandium, LLC against Ageos; (ii) other compensatory damages in connection with certain lease payments
under the lease discussed above; and (iii) pre-judgment interest. This lawsuit is ongoing, and its resolution is unknown.
Leases
In
February 2019, the Company and the landlord for its leased office space in Buda, Texas entered into a new lease agreement, and
the Company reduced its rented space from approximately 3,900 to 1,302 square feet. The new lease became effective on February
1, 2019 and has a three-year term. The initial monthly rent is $2,566, and the lease agreement provided for annual rent increases
of approximately 2.7%. The lease automatically renews for a three-year term, unless either party to the lease agreement notifies
the other of the intent to terminate the lease in writing at least 180 days prior to the expiration of the current term. In July
2020, the Company executed a lease termination agreement with the landlord for an early termination fee of $10,546 and forfeited
the existing security deposit of $2,566. There are no future payments related to this lease.
In
October 2018, the Company leased approximately 3,900 square feet of office space on North Scottsdale Road in Scottsdale, Arizona.
The lease for this facility began on October 4, 2018 and originally continued until October 31, 2021. Annual rent of $77,180 was
prepaid for the first year from November 1, 2018 to October 31, 2019, and the lease agreement provides for annual rent increases
of approximately 5.0%. In June 2020, the Company executed a lease termination agreement with the landlord for an early termination
fee of $27,013 and forfeited the existing security deposit of $9,796. There are no future payments related to this lease.
In
February 2020, the Company leased approximately 3,666 square feet of office space on 2107 Wilson Boulevard, Arlington, Virginia.
The lease for this facility began on February 1, 2020 and continues until July 31, 2025. The base annual rent is $159,471, a $100,000
security deposit was paid, and abatement of monthly rent payments was provided until August 1, 2020, and the lease provides for
annual rent increases of approximately 2.5%. The amount of future payments guaranteed is $822,082.
As
the result of restructuring actions intended to conserve cash during the COVID-19 crisis, the landlord of the Wilson Boulevard
space was notified that the Company no longer needed the space and is seeking an amicable and reasonable termination of the lease
agreement.
As
of September 30, 2020, the Company had one lease agreements for facilities.
Leases
with an initial term of 12 months or less are not recorded on our Balance Sheet; we recognize lease expense for these leases on
a straight-line basis over the lease term. Leases with initial terms in excess of 12 months are recorded as operating or financing
leases in our Balance Sheet.
Lease
assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the
lease term at commencement date. As most of our leases do not provide an implicit rate, we use a secured incremental borrowing
rates based on the information available at commencement date, including lease term, in determining the present value of future
payments. The operating lease asset also includes any lease payments made and excludes lease incentives and initial direct costs
incurred. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that the option will
be exercised.
27
At
inception, the Company determines if an arrangement contains a lease and whether that lease meets the classification criteria
of a finance or operating lease. Some of the Company’s lease arrangements contain lease components (e.g. minimum rent payments)
and non-lease components (e.g. maintenance, labor charges, etc.). The Company generally accounts for each component separately
based on the estimated standalone price of each component. For certain leases, the Company accounts for the lease and non-lease
components as a single lease component.
The
Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
Operating
Leases
Operating
leases are included in operating lease ROU lease assets, and operating lease liabilities and operating long-term lease liabilities
on the Balance Sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Variable
lease expense is recognized in the period in which the obligation for those payments is incurred. Lease expense is included in
general and administrative expense in the statements of operations and is reported net of lease income. Lease income is not material
to the results of operations for the quarter ended June 30, 2020. The Company announced a corporate restructuring on June 30,
2020 which will result in the abandonment of certain office spaces. The Company has recorded an impairment charge of approximately
$382,962 which is the estimate of the future payments less projected sublease income from the abandoned office space.
Cash
Flows
An
initial right-of-use asset of $233,751 was recognized as a non-cash asset addition with the adoption of the new lease accounting
standard. Cash paid for amounts included in the present value of operating lease liabilities was $28,534 during third quarter
2020 and is included in operating cash flows. In February 2020, the Company’s new lease in Arlington, Virginia added approximately
$746,000 in new lease obligations.
The
weighted average remaining lease terms and discount rates for all of our operating lease were as follows as of September 30, 2020:
Remaining lease term
and discount rate:
September
30, 2020
Weighted average remaining lease terms
(years)
Lease
facilities
4.83
Weighted average discount rate
Lease facilities
4.35 %
Significant
Judgements
Significant
judgements include the discount rates applied, the expected lease terms, and lease renewal options. There are three leases with
a renewal option. Using the practical expedient, the Company utilized existing lease classifications as of September 30, 2019.
As a result, the lease renewal options were not changed on implementation.
Future
annual minimum lease obligations at September 30, 2020 are as follows:
Year
ending September 30
Amount
2021
$ 162,135
2022
166,180
2023
170,322
2024
174,575
2025
148,870
$ 822,082
Rent
expense totaled $218,997 and $150,575 for the years ended September 30, 2020 and 2019, respectively.
28
NOTE
9 - STOCKHOLDERS’ EQUITY (DEFICIT)
Common
Stock
As
of September 30, 2020, and 2019, the Company had 27,505,196 and 40,792,510 shares of common stock outstanding, respectively, and
were authorized to issue 681,000,000 shares of common stock at a par value of $0.01.
Treasury
Stock
Management
determines the fair value of stock issuances using the closing stock price on the grant date.
During
the year ended September 30, 2020, the Company came to a settlement with First Fire and purchased back 149,557 shares and recorded
such shares as Treasury Stock. First Fire received $150,000 in exchange for the 149,557 shares.
During
the year ended September 30, 2020, the Company reached a settlement and as result received surrendered shares of 13,137,757 share
and recorded such shares as Treasury Stock.
Common
Stock Issued for Cash
During
the year ended September 30, 2019, the Company refunded $40,000 for an oversubscription of common stock made by an investor related
to the private placement of shares in fiscal year 2018. The refund was made in lieu of an issuance of shares.
Common
Stock and Stock Options Issued to Directors and Officers
During
the year ended September 30, 2019, the Company issued 9,346 vested shares of common stock with a fair value of $11,216 to an employee,
which was recorded as stock-based compensation expenses in research and development expense in the statement of operations.
During
the year ended September 30, 2019, the Company issued 1,100,000 shares of stock options to the Board of Directors and officers
with a fair value of $862,000, of which $42,942 was recorded as stock-based compensation expenses in research and development
and general administration expense. Options will vest over a three-year period ratably. Of the 1,100,000, 1,000,000 options have
a strike price of $0.85 and the remaining 100,000 have a strike price of $0.75.
During
2020, 620,000 stock options were granted to employees. Also during 2020, 920,000 stock options were cancelled due to the
termination of employment. As of September 30, 2020, 800,000 stock options are outstanding. None of the stock options are in the
money and the unamortized amount of stock compensation as of September 30, 2020 is $383,453.
Year Ended September 30, 2019
Balance on September 30, 2018
—
New
Awards
1,100,000
Options
Cancelled
—
Balance at September 30, 2019
1,100,000
Year Ended September 30, 2020
Balance on September 30, 2019
1,100,000
New Awards
620,000
Options
Cancelled
(920,000 )
Balance at September 30, 2020
800,000
Common
Stock Issued for Services
During
the year ended September 30, 2019, the Company issued 20,000 shares of common stock with a fair value of $40,000 to Pycnocline,
LLC for management consulting services, which was recorded in research and development expense.
29
Preferred
Stock
As
of September 30, 2020, and 2019, the Company had 1,000,000 and 1,000,000 shares of restricted preferred stock outstanding, respectively.
Each share of preferred stock is convertible into the Company’s common stock at a rate of one (1) preferred share to 1.5
common shares. Each share of preferred stock has 1.5 votes on all matters presented to be voted by the holders of common stock.
The holders of preferred stock can only convert the shares if agreed to by the Board of Directors. If declared by the Board of
Directors, holders of preferred stock are entitled to receive dividends prior and in preference to any declaration or payment
of any dividend on the common stock of the Company. In the event of liquidation or dissolution of the Company, holders of preferred
stock shall be paid out of the assets of the Company prior and in preference to any payment or distribution to holders of common
stock of the Company.
Warrants
During
the year ended September 30, 2018, the Company issued warrants to purchase 75,000 shares of common stock. These warrants were
issued with an exercise price of $2.00 and a term of five years. No warrants were issues during fiscal years 2020 and 2019.
Additionally,
in connection with shares sold through a PPM, the Company issued warrants to purchase 144,000 shares of common stock. These warrants
were issued with an exercise price of $4.50 and a term of two years.
Lastly,
in connection with shares sold through an additional PPM, the Company issued warrants to purchase 18,837,900 shares of common
stock. These warrants were issued with an exercise price of $1.20 and a term of five years. The company issued warrants to purchase
an additional 5,398,970 shares of common stock to its underwriters. These warrants were issued with an exercise price of $1.00
and a term of ten years.
Warrant
activity for the years ended September 30, 2020 and 2019 is as follows:
Number
of Warrants
Weighted
Average Exercise Price
Weighted
Average Remaining Life
Outstanding
at September 30, 2018
25,015,866
$
1.27
5.83
Granted
—
—
—
Exercised
—
—
—
Canceled/Forfeited
(725,000
)
4.50
—
Outstanding
at September 30, 2019
24,290,866
1.14
4.84
Granted
—
—
—
Exercised
—
—
—
Canceled/Forfeited
(544,000
)
2.11
—
Outstanding
at September 30, 2020
23,746,866
$
1.12
3.74
30
NOTE
10 - INCOME TAXES
The
provision (benefit) for income taxes from continued operations for the years ended September 30, 2020 and 2019 consist of the
following:
September
30,
2020
2019
Current:
Federal
$ —
$ —
State
—
—
$ —
$ —
Deferred:
Federal
$ (1,396,673 )
$ (1,301,000 )
State
—
—
(239,000 )
(1,301,000 )
Valuation
allowance
1,396,673
1,301,000
Provision
(benefit) for income taxes, net
$ —
$ —
The
difference between income tax expense computed by applying the federal statutory corporate tax rate and actual income tax expense
is as follows:
September
30,
2020
2019
Statutory federal income
tax rate
21.0 %
21.0 %
Non-deductible stock-based compensation
and other permanent differences
(0.1 )
(0.07 )
Change in statutory tax rate
(0.0 )
(13.0 )
Valuation allowance
(20.90 )
(20.93 )
Effective tax
rate
0.0 %
0.0 %
Deferred
income taxes result from temporary differences in the recognition of income and expenses for the financial reporting purposes
and for tax purposes. The tax effect of these temporary differences representing deferred tax asset and liabilities result principally
from the following:
September
30,
2020
2019
Net operating loss carry
forward
$ 6,126,911
$ 4,778,000
Deferred compensation
3,853,777
3,806,000
Valuation allowance
(9,980,688 )
(8,584,000 )
Deferred income
tax asset
$ —
$ —
The
Company has a net operating loss carry forward of $29.2 million available to offset future taxable income. Of which, $2.6 million
will expire within the next five years, and the remaining $26.6 million will expire thereafter. For income tax reporting purposes,
the Company’s aggregate unused net operating losses were subject to the limitations of Section 382 of the Internal Revenue
Code, as amended. The Company has adjusted the net operating losses incurred prior to 2015 to reflect only the losses not subject
to limitation. The Company has provided for a valuation reserve against the net operating loss benefit, because in the opinion
of management based upon the earning history of the Company; it is more likely than not that the benefits will not be realized.
For income tax reporting purposes, Management has determined that net operating losses prior to February 5, 2015 are subject to
an annual limitation of approximately $525,000.
For
the years ended September 30, 2020 and 2019, the difference between the amounts of income tax expense or benefit that would result
from applying the statutory rates to pretax income to the reported income tax expense of $0 is the result of the net operating
loss carry forward and the related valuation allowance, as well as non-deductible stock-based compensation.
The
Company anticipates it will continue to record a valuation allowance against the losses of certain jurisdictions, primarily federal
and state, until such time as it is able to determine it is “more-likely-than-not” the deferred tax asset will be
realized. Such position is dependent on whether there will be sufficient future taxable income to realize such deferred tax assets.
The Company’s effective tax rate may vary from period to period based on changes in estimated taxable income or loss by
jurisdiction, changes to the valuation allowance, changes to federal, state or foreign tax laws, future expansion into areas with
varying country, state, and local income tax rates, deductibility of certain costs and expenses by jurisdiction.
The
Company is current on all its federal income tax filings. An extension will be filed for the September 30, 2020 tax return.
On
December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law in the U.S. The Tax Act has resulted
in significant changes to the U.S. corporate income tax system. These changes include a federal statutory rate reduction from
35% to 21%, the elimination or reduction of certain domestic deductions and credits, and limitations on the deductibility of interest
expense and executive compensation. These changes were effective beginning in 2018.
NOTE
11 - SUBSEQUENT EVENTS
On
October 16, 2020, David Chasteen, a director, was appointed the Chief Executive Officer of the Company.
On
November 12, 2020, Milton Mattox, Cipherloc Chief Operating Officer, tendered his resignation which was accepted by the Chief
Executive Officer. Mattox assisted in the transition to interim Chief Technology Officer Nick Hnatiw who was engaged as an independent
contractor on November 18, 2020. Mattox’s last day with the Company was December 15, 2020.
31
ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
ITEM
9A. CONTROLS AND PROCEDURES
Evaluation
of Disclosure Controls and Procedures
We
maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports
we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in
the Securities and Exchange Commission’s (the “SEC”) rules and forms and that such information is accumulated
and communicated to our Chief Executive Officer and Principal Financial Officer, as appropriate, to allow for timely decisions
regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that
any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the
desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible
controls and procedures. Our disclosure controls and procedures have not been formally designed and evaluated to provide reasonable
assurance that the controls and procedures would meet their objectives.
As
required by SEC Rule 13a-15(b), our Chief Executive Officer and Principal Financial Officer need to carry out an evaluation of
the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by
this report. Based on the foregoing, our Chief Executive Officer and Principal Financial Officer concluded that our disclosure
controls and procedures were not effective as of September 30, 2020, due to 1) no formal evaluation has been performed by us and
2) the existence of the material weaknesses in internal control over financial reporting described below (which we view as an
integral part of our disclosure controls and procedures). Based on the performance of additional procedures designed to ensure
the reliability of our financial reporting, we believe that the financial statements included in this Annual Report fairly present,
in all material respects, our financial position, results of operations and cash flows as of the dates, and for the periods, presented,
in conformity with U.S. GAAP.
Management’s
Report on Internal Control over Financial Reporting
Our
Chief Executive Officer and the Principal Financial Officer are responsible for establishing and maintaining adequate internal
control over financial reporting and for the assessment of the effectiveness of our internal control over financial reporting.
Internal control over financial reporting (as defined in Rules 13a-15(f) and 15d(f) under the Exchange Act) is a process designed
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external reporting purposes in accordance with U.S. GAAP. Internal control over financial reporting includes those policies and
procedures that (a) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions
and dispositions of assets, (b) provide reasonable assurance that transactions are recorded as necessary to permit preparation
of financial statements in accordance with GAAP, (c) provide reasonable assurance that receipts and expenditures are being made
only in accordance with appropriate authorization of management and the Board of Directors, and (d) provide reasonable assurance
regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material
effect on the financial statements.
In
connection with the preparation of the Annual Report on Form 10-K for the year ended September 30, 2019, our Chief Executive Officer
and Principal Financial Officer evaluated the effectiveness of our internal control over financial reporting as of September 30,
2019 and concluded that we had not implemented effective internal control over financial reporting during the reporting year.
Remediation
Plan
Management
executed a remediation plan to address the material weaknesses discussed above. These remediation efforts focused on:
●
Enhancing
monitoring and review controls over financial reporting and disclosures;
●
Enhancing
review and approval controls around transaction processing;
●
Enhancing
controls around proving the delivery of software; and
●
Enhancing
and maintaining written policies and procedures for accounting and financial reporting.
Subsequent
to September 30, 2019, management designed and implemented review and approval controls around transaction processing, including
written policies and procedures. In addition, management has continued to train key accounting staff to improve controls that
will eliminate the material weaknesses discussed above, as well as improve the accounting and financial reporting process.
Management
has also evaluated the effectiveness of its internal control over financial reporting in accordance with generally accepted accounting
principles within the guidelines of the Committee of Sponsoring Organizations of the Treadway Commission framework (2013). Based
on the results of this evaluation, management has determined that the Company’s internal control over financial reporting
was effective as of September 30, 2020.
32
Changes
in Internal Control over Financial Reporting
During
the year ended September 30, 2020, there were no changes in our internal control over financial reporting that have materially
affected or are reasonably likely to materially affect our internal control over financial reporting, other than the remediation
actions discussed above.
Inherent
Limitations on Internal Controls
It
should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute
assurance that the objectives of the control system are met. In addition, the design of any control system is based in part upon
certain assumptions about the likelihood of certain events. Limitations inherent in any control system include the following:
●
Judgments
in decision-making can be faulty, and control and process breakdowns can occur because of simple errors or mistakes;
●
Controls
can be circumvented by individuals, acting alone or in collusion with others, or by management override;
●
The
design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there
can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions;
●
Over
time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with associated
policies or procedures; and
●
The
design of a control system must reflect the fact that resources are constrained, and the benefits of controls must be considered
relative to their costs.
Because
of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control
issues and instances of fraud, if any, have been detected.
ITEM
9B. OTHER INFORMATION
None.
33
PART
III
ITEM
10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE
Directors
and Executive Officers
Set
forth below is information regarding the Company’s current directors and executive officers. There are no family relationships
between any of our directors or executive officers. The directors are elected annually by our stockholders. The executive officers
serve at the pleasure of the Board of Directors.
Name
Age
Title
Tom
Wilkinson
51
Chairman
of the Board of Directors
Anthony
Ambrose
59
Director
David
Chasteen
43
Chief
Executive Officer and Director
Sammy
Davis DrPH
73
Director
Zeynep
Young
50
Director
Ryan
Polk
52
Chief
Financial Officer
Milton
Mattox
58
Chief
Operating Officer
Nicholas
Hnatiw
40
Interim
Chief Technology Officer
The
background and principal occupations of the directors and executive officers of the Company are as follows:
Board
of Directors
Tom
Wilkinson – Chairman of the Board of Directors
Mr.
Wilkinson serves as the Company’s Chairman of the Board of Directors. He is a licensed CPA in Texas and Colorado. From 2014
to October, 2015 he was the Chief Financial Officer of Amherst Holdings, LLC. Mr. Wilkinson joined Xplore Technologies Corp.,
a NASDAQ traded company, in 2015 where he served as the Chief Financial Officer until 2017 when he took on the position of Chief
Executive Officer until the sale of the company to Zebra Technologies in August 2018. He presently owns and operates Wilkinson
& Company, a financial and business consulting firm focused on emerging growth pre-IPO and public companies. Mr. Wilkinson
has also been a member of the board of directors of Astrotech Corporation (NASDAQ: ASTC) since October 2018. He received his Bachelor
of Business Administration and Master of Professional Accounting from the University of Texas in 1992. We believe Mr. Wilkinson
is qualified to serve on our board of directors based on his financial experience.
Anthony
Ambrose – Director
Mr.
Ambrose serves a director of the Company. Mr. Ambrose has served as a director, President and Chief Executive Officer of Data
I/O, the leading global provider of advanced data and security programming solutions, and a NASDAQ listed company (NASDAQ: DAIO).
Prior to Data I/O, Mr. Ambrose was Owner and Principal of Cedar Mill Partners, LLC, a strategy consulting firm since 2011. From
2007 to 2011, he was Vice President and General Manager at RadiSys Corporation, a leading provider of embedded wireless infrastructure
solutions, where he established the telecom platform business and grew it to over $125M in annual revenues. He was previously
general manager and held several other progressively responsible positions at Intel Corporation, where he led development and
marketing of standards-based communications platforms and grew the industry standard server business to over $1B in revenues.
Mr. Ambrose has a Bachelor of Science degree in Engineering from Princeton University, and has completed the Stanford University
Director Symposium. We believe Mr. Ambrose is
qualified to serve on our board of directors based on his data security and industry experience.
34
David
Chasteen – Chief Executive Officer and Director
Mr.
Chasteen serves as a director of the Company. Since 2018, Mr. Chasteen has been the Chief Information Security Officer for the
City and County of San Francisco Police Department. From 2015 to 2018, Mr. Chasteen was a Threat Intelligence Strategist for the
City and County of San Francisco where he was responsible for managing city, state and federal intelligence relationships and
managing cybersecurity operations for the City and County of San Francisco. From 2015 to 2016 Mr. Chasteen was the Western Regional
Director for Iraq and Afghanistan Veterans of America. From 2006 to 2014 Mr. Chasteen worked for the Central Intelligence Agency
as a Collection Management Officer, Specialized Skills Officer, and finally an Executive Officer, Covert Action Staff. Mr. Chasteen
received a B.S. in Political Science from Ball State University in 2000. We believe Mr. Chasteen is qualified to serve on our
board of directors based on his cybersecurity and industry experience.
Sammy
Davis DrPH – Director
Dr.
Davis serves as a director of the Company. Dr. Davis has over 20 years’ experience in operations, finance, budgeting, financial
reporting, revenue cycle management, inventory, payroll, accounts receivable and payable, and information systems in the healthcare
industry. Since 2009 Dr. Davis has been a Senior Marketing Liaison with Physician Reliance Corporation. From 2005 to 2009, Dr.
Davis was the Chief Executive officer of Renaissance Hospital in the Dallas/Fort Worth Area. From 2004 to 2005, Dr. Davis was
the interim Chief Executive Officer of Transition Health Care LTAC in Corpus Christi, TX. Dr. Davis holds a Doctor of Public Health
degree from the University of Texas. We believe Dr. Davis is qualified to serve on our board of directors based on his leadership
experience.
Zeynep
Young – Director
Ms.
Young serves as a director of the Company. Since 2017, Ms. Young has been a Venture Partner with Next Coast Ventures, a venture
capital firm focused on providing early-stage capital to high-growth startups. In 2017 Ms. Young served as interim chief executive
officer of Milk & Honey, a wellness and beauty company with a portfolio of day spas, salons and products in the organic, luxury
market. From 2009 to 2016, Ms. Young was the Founder and Chief Executive Officer of Double Line, Inc., a management consulting
firm. Ms. Young received a B.A. in Economics and Sociology from Rice University in 1992 and an M.B.A. from Northwestern University
– Kellogg School of Management in 1997. We believe Ms. Young is qualified to serve on our board of directors based on her
business and leadership experience.
35
Executive
Officers
Ryan
Polk – Chief Financial Officer
Ryan
Polk serves as the Company’s Chief Financial Officer. Mr. Polk has served in leadership roles in both public and private
companies after a brief time at accounting firm Ernst & Young. He is a part-time employee of Cipherloc and is engaged in providing
CEO and CFO related services to other companies as an independent contractor. He is a graduate of Purdue University with two Bachelor
of Science degrees from the Krannert School of Management. His career has focused on both the consumer products and technology
industries.
Milton
Mattox – Chief Operating Officer
Milton
Mattox serves as the Company’s Chief Operating Officer. Mr. Mattox is an experienced, senior technology executive with an
extensive background in software engineering, application development, IT infrastructure, and offshore research and development
team management. His accomplishments include transforming and accelerating technology development and delivery in alignment with
worldwide business goals. His professional experience includes an executive vice president position at Lucent Technologies with
executive-level experience at Intuit, Mitel, SHPS, Narus India, Signa, and CGI. Mr. Mattox holds a Doctorate in Organization and
Leadership from the University of San Francisco, an MBA from City University of Seattle, and a Bachelor of Science in Electronic
Engineering Technology from DeVry University.
Nicholas
Hnatiw – Interim Chief Technology Officer
Nicholas
Hnatiw serves as the Company’s Chief Technology Officer. Mr. Hnatiw has more than 15 years of experience creating software
technologies from network security to artificial intelligence. Mr. Hnatiw has led the design and development of a security risk
assessment SaaS platform, run a security monitoring service with a custom-built next generation automation and SIEM system. Prior
to the Company, Mr. Hnatiw served as the technical director for network operations supporting U.S. Cyber Command, U.S. Intelligence
Agencies, and other Department of Defense research organizations from October 2010 to October 2014. From June 2015 to September
2019, Mr. Hnatiw was the Chief Executive Officer of Loki Labs, a cyber security firm. Mr. Hnatiw is also currently a consultant
with Cuesta Partners (since January 2020); a partner and Chief Technology Officer of Sidechannel Security (since February 2020),
and the Chief Technology Officer of RealCISO.io (since October 2020). Mr. Hnatiw earned a bachelor of science degree in computer
engineering and computer science at the University of Massachusetts, Amherst.
Family
Relationships and Other Arrangements
There
are no family relationships among our directors and executive officers. Other than Mr. Chasteen’s appointment as a chief
executive officer in connection with his employment agreement, there are no arrangements or understandings between or among our
executive officers and directors pursuant to which any director or executive officer was or is to be selected as a director or
executive officer.
Board
Leadership Structure and Role in Risk Oversight
Our
Board has established an audit committee, a compensation committee, and a nominating and corporate governance committee, each
of which operate pursuant to a charter adopted by our Board. Each committee has the composition and responsibilities described
below. Our Board may establish other committees from time to time.
The
following table identifies the current members of each of our committees:
Name
Executive
Committee
Audit
Compensation
Corporate
Governance/
Nominating
Tom Wilkinson
X*
X
X
X
Anthony Ambrose
X
X*
X
X*
David Chasteen
X
Sammy Davis DrPH
X
X
X
X
Zeynep Young
X
X
X*
X
*
Chairman of the committee
Director
Independence
Our
Board has determined that a majority of the Board consists of members who are currently “independent” as that term
is defined under the rules of the Nasdaq Stock Market LLC. As our common stock is traded over the counter on the OTCQB, we are
not required to comply with such requirements. Nevertheless, the Board considers Ms. Young, Dr. Davis, and Mr. Ambrose to be “independent”
under such rules.
Audit
Committee
Messrs.
Ambrose, Wilkinson, Davis and Ms. Young serve on the Audit Committee, which is chaired by Mr. Ambrose.
The
audit committee’s responsibilities include:
●
appointing,
approving the compensation of, and assessing the independence of our independent registered public accounting firm;
●
pre-approving
auditing and permissible non-audit services, and the terms of such services, to be provided by our independent registered
public accounting firm;
36
●
reviewing
the overall audit plan with our independent registered public accounting firm and members of management responsible for preparing
our financial statements;
●
reviewing
and discussing with management and our independent registered public accounting firm our annual and quarterly financial statements
and related disclosures as well as critical accounting policies and practices used by us;
●
coordinating
the oversight and reviewing the adequacy of our internal control over financial reporting;
●
establishing
policies and procedures for the receipt and retention of accounting-related complaints and concerns;
●
recommending
based upon the audit committee’s review and discussions with management and our independent registered public accounting
firm whether our audited financial statements will be included in our Annual Reports on Form 10-K;
●
monitoring
the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to our
financial statements and accounting matters;
●
preparing
the audit committee report required by SEC rules to be included in our annual proxy statement;
●
reviewing
all related person transactions for potential conflict of interest situations and approving all such transactions; and
●
reviewing
quarterly earnings releases.
Compensation
Committee
Messrs.
Ambrose, Wilkinson, Davis and Ms. Young serve on the Compensation Committee, which is chaired by Ms. Young
The
compensation committee’s responsibilities include:
●
annually
reviewing and approving corporate goals and objectives relevant to the compensation of our chief executive officer;
●
evaluating
the performance of our chief executive officer considering such corporate goals and objectives and determining the compensation
of our chief executive officer;
●
reviewing
and approving the compensation of our other executive officers;
●
reviewing
and establishing our overall management compensation, philosophy and policy;
●
overseeing
and administering our compensation and similar plans;
●
evaluating
and assessing potential and current compensation advisors in accordance with the independence standards identified in the
applicable Nasdaq rules;
●
retaining
and approving the compensation of any compensation advisors;
●
reviewing
and making recommendations to our Board about our policies and procedures for the grant of equity-based awards;
●
evaluating
and making recommendations to the Board about director compensation;
●
preparing
the compensation committee report required by SEC rules, if and when required, to be included in our annual proxy statement;
and
●
reviewing
and approving the retention or termination of any consulting firm or outside advisor to assist in the evaluation of compensation
matters.
37
Corporate
Governance/Nominating Committee
Messrs.
Ambrose, Wilkinson, Davis and Ms. Young serve on the Corporate Governance/Nominating Committee, which is chaired by Mr. Ambrose.
The
nominating and corporate governance committee’s responsibilities include:
●
developing
and recommending to the Board criteria for board and committee membership;
●
establishing
procedures for identifying and evaluating board of director candidates, including nominees recommended by stockholders;
●
reviewing
the size and composition of the Board to ensure that it is composed of members containing the appropriate skills and expertise
to advise us;
●
identifying
individuals qualified to become members of the Board;
●
recommending
to the Board the persons to be nominated for election as directors and to each of the board’s committees;
●
developing
and recommending to the Board a code of business conduct and ethics and a set of corporate governance guidelines; and
●
overseeing
the evaluation of our Board and management.
Conflicts
of Interest
Members
of our management are associated with other firms involved in a range of business activities. Consequently, there are potential
inherent conflicts of interest in their acting as officers and directors of our company. Although the directors are engaged in
other business activities, we anticipate they will devote an important amount of time to our affairs.
Our
officers and directors are now and may in the future become shareholders, officers or directors of other companies, which may
be formed for the purpose of engaging in business activities similar to ours. Accordingly, additional direct conflicts of interest
may arise in the future with respect to such individuals acting on behalf of us or other entities. Moreover, additional conflicts
of interest may arise with respect to opportunities which come to the attention of such individuals in the performance of their
duties or otherwise. Currently, we do not have a right of first refusal pertaining to opportunities that come to their attention
and may relate to our business operations.
Our
officers and directors are, so long as they are our officers or directors, subject to the restriction that all opportunities contemplated
by our plan of operation which come to their attention, either in the performance of their duties or in any other manner, will
be considered opportunities of, and be made available to us and the companies that they are affiliated with on an equal basis.
A breach of this requirement will be a breach of the fiduciary duties of the officer or director. If we or the companies with
which the officers and directors are affiliated both desires to take advantage of an opportunity, then said officers and directors
would abstain from negotiating and voting upon the opportunity. However, all directors may still individually take advantage of
opportunities if we should decline to do so. Except as set forth above, we have not adopted any other conflict of interest policy
with respect to such transactions.
Code
of Ethics
We
have adopted a formal Code of Ethics applicable to all Board members, officers and employees. A copy of our Code of Ethics may
be obtained without charge upon written request to Secretary, Cipherloc Corporation, 6836 Bee Cave Road, Bldg. 1, S#279, Austin,
TX 78746.
38
ITEM
11. EXECUTIVE COMPENSATION
Summary
Compensation Table
The
following tables set forth certain information concerning all compensation paid, earned or accrued for service by (i) our Principal
Executive Officer and Principal Financial Officer and (ii) all other executive officers who earned in excess of $100,000 in the
fiscal years ended September 30, 2020 and 2019, and each of the other two most highly compensated executive officers of the Company
who served in such capacity at the end of the fiscal year whose total salary and bonus exceeded $100,000 (collectively, the “Named
Executive Officers”):
SUMMARY
COMPENSATION TABLE
Name
and Position
Year
Salary
($)
Bonus
($)
Stock
Awards ($)
All
Other Compensation ($) (1)
Change
in Pension Value and Nonqualified Deferred Compensation Earnings ($)
Total
($)
Tom Wilkinson
Chairman of the Board & Principal
Financial Officer
2020
$ —
—
$ —
$ —
—
$ —
Executive Officer
2019
$ 25,000
—
$ 96,500
$ 10,000
—
$ 131,500
Andrew Borene
Chairman &
2020
$ 94,500
$ 100,000
—
$ 175,000
—
$ 369,500
Chief Executive Officer (2)
2019
$ —
—
—
$ —
—
$ —
Ryan Polk,
Chief Financial Officer (3)
2020
$ 49,760
—
—
$ —
—
$ 49,760
Gino Mauriello
2020
$ 72,917
—
—
$ 50,000
—
$ 122,917
Chief Financial
2019
$ 93,750
—
—
—
—
$ 93,750
Officer (4)
Albert Carlson, PhD
Director &
2020
$ 121,890
—
—
—
—
$ 121,890
Chief Scientific
2019
$ 200,833
—
$ 57,900
—
—
$ 258,733
Officer (6)
Milton Mattox
2020
$ 222,865
$ 15,000
$ —
—
—
$ 237,865
Chief Operating
2019
$ 185,417
—
$ 19,300
—
—
$ 204,717
Officer (5)
(1)
All other compensation consists primarily of remunerations for legal settlements, severance, auto and health insurance costs.
(2)
Mr. Andrew Borene was terminated as Chief Executive Officer on April 3, 2020.
(3)
Mr. Polk was appointed as Chief Financial Officer on February 1, 2020.
(4)
Mr. Mauriello was terminated as Chief Financial Officer on December 13, 2019.
(5)
Mr. Mattox resigned from the Company on November 12, 2020.
(6)
Mr. Carlson resigned from the Company on December 17, 2019
Compensation
of Directors
We
changed our compensation policy for directors include quarterly fees as well as stock options. Annual director compensation
will be $60,000 for the Chairman of the Board and Lead Independent Director, $40,000 for directors with an additional $4,000 for
additional committees. During the years ended September 30, 2020 and 2019, the company paid $170,000 and $40,000 in board fees,
respectively. During July 2020, the board of directors temporarily deferred cash director payments.
Employment
Contracts
Borene
Employment Agreement
We
entered into an Employment Agreement with Andrew Borene (the “Borene Employment Agreement”), our Chief Executive Officer,
on November 25, 2019, pursuant to which he received a base annual salary of $350,000, payable in accordance with the Company’s
standard payroll schedule, and other customary benefits. Mr. Borene also received options to purchase up to 500,000 shares of
the Company’s common stock (the “Borene Options”). The Borene Options had an exercise price of $0.75 per share
and were to vest as follows: 166,666 shares vest on November 26, 2020, 166,667 shares vest on November 26, 2021, and 166,667 shares
vest on November 26, 2022. Additionally. Mr. Borene received a signing bonus in the amount of $150,000 which is payable in equal
installments at the end of each of the first three months of his employment.
Mr.
Andrew Borene was terminated on April 3, 2020. No future payments are expected under his former employment contract.
39
Carlson
Employment Agreement
We
previously entered into an employment agreement with Albert Carlson as our Chief Scientific Officer. Dr. Carlson resigned from
his positions as Chief Scientific Officer and director on December 17, 2019. The agreement was for a term of one year, commencing
on September 1, 2015 and initially expired on August 31, 2016 with three one-year extensions. The Agreement provided that, in
addition to receiving paid vacation in accordance with the Company’s policies as well as other customary benefits and provisions,
Dr. Carlson received an annual base salary of $150,000. If, at any time during the term of the Agreement, Dr. Carlson was terminated
“without cause,” he was entitled to receive a cash payment equal to the aggregate compensation payable to him during
the remaining term of the Agreement. During the year ended September 30, 2019, prior to his resignation, Dr. Carlson’s annual
base salary was increased to $300,000.
De
La Garza Employment Agreement
The
Company entered into an employment agreement with Michael De La Garza, its former Chief Executive Officer, on January 1, 2013.
The employment agreement was initially set to expire on January 1, 2018 and automatically renews for another five years unless
Mr. De La Garza was terminated in accordance with the provisions of the employment agreement. Mr. De La Garza was terminated on
August 11, 2019. The employment agreement provided for:
i.
A
monthly salary of $20,833 per month subject to an annual increase of 10% per year and consistent with the Company policy applicable
to other senior executives and officers and approval by the Board of Directors. During the year ended September 30, 2018,
the base salary was $360,000.
ii.
A
cash bonus of 25% of his annual base salary each year if the Company reaches the following milestones:
a.
The
Company posts annual gross revenues on a consolidated basis of at least $5,000,000;
b.
The
Company’s earnings before the deduction of income taxes and amortization expenses (“EBITA”), including cash
extraordinary items but before officer’s bonuses, on a consolidated basis for any year is at least $1,000,000;
iii.
An
automobile allowance of $1,500 per month.
iv.
A
medical insurance allowance of $1,500 per month.
v.
In
the event the executive’s employment is terminated without cause, he will receive the entire contract remaining on the
agreement.
Mr.
De La Garza was terminated on August 11, 2019 for cause. No future payments are expected under his former employment contract.
All
Claims with MDLG were settled. Please refer to Note 8 to our audited financial statements included in this Annual Report on Form
10-K.
40
2019
Stock Incentive Plan
Our
Board adopted our 2019 Stock Incentive Plan on August 8, 2019. Our stockholders have not yet approved the adoption of the 2019
Stock Incentive Plan. Our 2019 Stock Incentive Plan is intended to align the interests of our stockholders and the recipients
of awards under the 2019 Stock Incentive Plan, and to advance our interests by attracting and retaining directors, officers, employees
and other service providers and motivating them to act in our long-term best interests. The material terms of the 2019 Stock Incentive
Plan are as follows:
Plan
term . The 2019 Stock Incentive Plan terminates on August 7, 2029 (the day before the tenth anniversary of the adoption of
the plan), unless terminated earlier by our Board.
Eligible
participants . All officers, directors, employees, consultants, agents and independent contractors, and persons expected to
become officers, directors, employees, consultants, agents and independent contractors of our Company or any of our subsidiaries
are eligible to receive awards under the 2019 Stock Incentive Plan. The compensation committee of our Board will determine the
participants under the 2019 Stock Incentive Plan.
Shares
authorized . 3,000,000 shares of common stock are available for awards granted under the 2019 Stock Incentive Plan, subject
to adjustment for stock splits and other similar changes in capitalization. The number of available shares will be reduced by
the aggregate number of shares that become subject to outstanding awards granted under the 2019 Stock Incentive Plan. To the extent
that shares subject to an outstanding award granted under the 2019 Stock Incentive Plan are not issued or delivered by reason
of the expiration, termination, cancellation or forfeiture of such award or by reason of the settlement of an award in cash, then
those shares will again be available under the 2019 Stock Incentive Plan. In addition, any shares covered by an award that have
been surrendered in connection with the payment of the award exercise or purchase price or in satisfaction of tax withholding
obligations incident to the grant, exercise, vesting or settlement of an award will be deemed not to have been issued for purposes
of determining the maximum number of shares which may be issued pursuant to all awards under the 2019 Stock Incentive Plan.
Award
types . Awards include options (non-qualified and incentive stock options) and restricted stock.
Administration .
The compensation committee will interpret and administer the 2019 Stock Incentive Plan. The compensation committee’s interpretation,
construction and administration of the 2019 Stock Incentive Plan and all its determinations thereunder will be conclusive and
binding on all persons.
The
compensation committee shall have the authority to determine the participants in the 2019 Stock Incentive Plan, the form, amount
and timing of any awards, the performance goals, if any, and all other terms and conditions pertaining to any award. The compensation
committee may take any action such that (i) any outstanding options become exercisable in part or in full, (ii) all or any portion
of a restriction period on any restricted stock will lapse, (iii) all or a portion of any performance period applicable to any
performance-based award will lapse and (iv) any performance measures applicable to any outstanding award will be deemed satisfied
at the target level or any other level. Subject to the terms of the 2019 Stock Incentive Plan relating to grants to our executive
officers and directors, the compensation committee may delegate some or all of its powers and authority to the Chief Executive
Officer or other executive officer as the compensation committee deems appropriate.
Stock
options . The 2019 Stock Incentive Plan provides for the grant of stock options. Stock options may be either tax-qualified
incentive stock options or non-qualified stock options. The compensation committee will determine the terms and conditions to
the exercisability of each option.
The
period for the exercise of a non-qualified stock option will be determined by the compensation committee provided that no option
may be exercised later than ten years after its date of grant. The exercise price of a non-qualified stock option will not be
less than 100% of the fair market value of a share of our common stock on the date of grant.
Each
incentive stock option will be exercisable for not more than 10 years after its date of grant, unless the optionee owns greater
than 10% of the voting power of all shares of our capital stock, or a “ten percent holder,” in which case the option
will be exercisable for not more than five years after its date of grant. The exercise price of an incentive stock option will
not be less than the fair market value of a share of our common stock on its date of grant, unless the optionee is a ten percent
holder, in which case the option exercise price will be the price required by the Internal Revenue Code of 1986, as amended, or
the “Code,” currently 110% of fair market value.
Upon
exercise, the option exercise price may be paid in cash, by the delivery of previously owned shares of our common stock, share
withholding or through a cashless exercise arrangement, as permitted by the applicable award agreement. All of the terms relating
to the exercise, cancellation or other disposition of an option upon a termination of employment, whether by reason of disability,
retirement, death or any other reason, will be determined by the compensation committee.
The
compensation committee, without stockholder approval, may (i) reduce the exercise price of any previously granted option, or (ii)
cancel any previously granted option at a time when its exercise price exceeds the fair market value of the underlying shares,
in exchange for another option, or other award or for cash.
41
Stock
awards . The 2019 Stock Incentive Plan provides for the grant of stock awards. The compensation committee may grant a stock
award as a restricted stock award and the compensation committee may determine that such award will be subject to the attainment
of performance measures over an established performance period. All of the terms relating to the satisfaction of performance measures
and the termination of a restriction period, or the forfeiture and cancellation of a stock award upon a termination of employment,
whether by reason of disability, retirement, death or any other reason, will be determined by the compensation committee.
Unless
otherwise set forth in a restricted stock award agreement, the holder of shares of restricted stock will have rights as our stockholder,
including the right to vote and receive dividends with respect to the shares of restricted stock, except that distributions other
than regular cash dividends and regular cash dividends with respect to shares of restricted stock subject to performance-based
vesting conditions will be held by us and will be subject to the same restrictions as the restricted stock.
Performance
goals . Under the 2019 Stock Incentive Plan, the vesting or payment of performance-based awards will be subject to the satisfaction
of certain performance goals. The performance goals applicable to a particular award will be determined by the compensation committee
at the time of grant. The performance goals may be one or more of the following corporate-wide or subsidiary, division, operating
unit or individual measures, stated in either absolute terms or relative terms.
Individual
Limits . With respect to non-employee directors, the maximum grant date fair value of shares that may be granted to an individual
non-employee director during any fiscal year of the Company is $150,000. In connection with a non-employee director’s commencement
of service with the Company, the per person limit set forth in the previous sentence will be $150,000.
Amendment
or termination of the 2019 Stock Incentive Plan . Our Board may amend or terminate the 2019 Stock Incentive Plan as it deems
advisable, subject to any requirement of stockholder approval required by law, rule or regulation.
Change
in control . In the event there is a change in control and/or the Company is a party to a merger or acquisition or reorganization
or Change in Control event or similar transaction, outstanding awards shall be subject to the merger agreement or other applicable
transaction agreement. Such agreement may provide, without limitation, that subject to the consummation of the applicable transaction,
for the assumption (or substitution) of outstanding awards by the surviving corporation or its parent, for their continuation
by the Company (if the Company is a surviving corporation), for accelerated vesting or for their cancellation with or without
consideration, or for the mandatory exercise or conversion of awards into shares and/or cash whether by net exercise or otherwise,
in all cases without the consent of a participant of the 2019 Stock Incentive Plan.
Additionally,
in the event a change in control occurs and there is no assumption, substitution or continuation of awards, the compensation committee
in its discretion may provide that all awards shall vest and become exercisable as of immediately before such change in control.
The compensation committee may also in its discretion include in an award agreement a requirement that unless approval under Section
280G of the Code has been obtained, no acceleration of vesting shall occur with respect to an award to the extent that such acceleration
would, after taking into account any other payments in the nature of compensation to which the participant would have a right
to receive from the Company and any other person contingent upon the occurrence of such change in control, result in a “parachute
payment” as defined under Code Section 280G.
Under
the 2019 Stock Incentive Plan, a change of control will occur upon: (i) the consummation of an acquisition, a merger or consolidation
of the Company with or into another entity or any other corporate reorganization, if more than 50% of the combined voting power
of the continuing or surviving entity’s securities outstanding immediately after such acquisition, merger, consolidation
or other reorganization is owned by persons who in the aggregate owned less than 20% of the Company’s combined voting power
represented by the Company’s outstanding securities immediately prior to such acquisition, merger, consolidation or other
reorganization; (ii) A sale of more than fifty percent (50%) of the outstanding shares of each class of capital stock of the Company
to a person, entity or group other than a person, entity or group affiliated with the Company, or (iii) he sale, transfer or other
disposition of all or substantially all of the Company’s assets to a person, entity or group other than a person, entity
or group affiliated with the Company.
New
plan benefits . The benefits that might be received by officers, employees and non-employee directors cannot be determined
at this time. All officers, employees and non-employee directors are eligible for consideration to participate in the 2019 Stock
Incentive Plan.
42
ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The
following table sets forth certain information regarding beneficial ownership of our common stock as of January 9, 2021 by (i)
each person (or group of affiliated persons) who is known by us to own more than five percent (5%) of the outstanding shares of
our common stock, (ii) each director and executive officer, and (iii) all of our directors and executive officers as a group.
As of January 9, 2021, there were 27,505,196 shares of our common stock issued and outstanding.
Except
as otherwise indicated, the persons listed below have sole voting and investment power with respect to all shares of our common
stock owned by them, except to the extent that power may be shared with a spouse.
Beneficial
ownership is determined in accordance with SEC rules and generally includes voting or investment power with respect to securities.
For purposes of this table, a person or group of persons is deemed to have “beneficial ownership” of any shares of
common stock that such person currently owns or has the right to acquire within 60 days of the date of this prospectus. With respect
to options and warrants, this would include options and warrants that are currently exercisable within 60 days. With respect to
convertible securities, this would include securities that are currently convertible within 60 days.
Except
as indicated in footnotes to this table, we believe that the stockholders named in this table have sole voting and investment
power with respect to all shares of common stock shown to be beneficially owned by them, based on information provided to us by
such stockholders. Unless otherwise indicated, the address for each director and executive officer listed is: c/o Cipherloc Corporation,
6836 Bee Cave Road, Bldg. 1, S#279, Austin, TX 78746.
Name
and Address of Beneficial Owners
Amount
Percent
Ownership
Tom Wilkinson
15,200
* %
Anthony Ambrose
—
— %
David Chasteen
—
— %
Sammy Davis, DrPH
10,000
* %
Zeynep Young
—
— %
Ryan Polk
—
— %
Milton Mattox
—
— %
Nicholas Hnatiw
—
— %
All Officers and
Directors as a Group (9 persons)
25,200
— %
5% or greater
%
Manchester Management
PR, LLC (1)
3,861,000
14.03 %
*
Less than 1%
(1)
Solely based on the Company’s review of public filings made with the SEC. Includes shares that are directly owned by Manchester
Explorer, L.P. The shares are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company,
LLC as a result of having investment discretion over certain advisory accounts they manage. Manchester Management PR, LLC, a Puerto
Rico limited liability company, provides investment management services to private individuals and institutions. The reported
securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management
PR, LLC and Manchester Management Company, LLC. The principal business address for Manchester Management PR, LLC is 53 Palmeras
Street, Caribe Plaza Building, 6th Floor, San Juan, Puerto Rico, 00901
43
ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The
following includes a summary of transactions during our fiscal years ended September 30, 2020 and September 30, 2019 to which
we have been a party, including transactions in which the amount involved in the transaction exceeds the lesser of $120,000 or
1% of the average of our total assets at year-end for the last two completed fiscal years, and in which any of our directors,
executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate
family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation,
termination, change in control and other arrangements, which are described elsewhere in this Annual Report on Form 10-K.
De
La Garza Settlement
On
August 28, 2020, we entered into a Settlement Agreement and Mutual General Release (the “Settlement”) with Michael
De La Garza, a former director of the Company. The Settlement related to certain actions, including (i) CipherLoc Corporation
vs. Michael De La Garza, MSR, LLC, and James LaGanke, as Trustee of the Caramel Trust II, Civil Action No. 1:19-CV-01147-LY in
the United States District Court for the Western District of Texas, Austin Division, (ii) CipherLoc Corporation vs. Michael De
La Garza, Cause No. D-1-GN-19-005253 in the 53 rd Judicial District Court of Travis County, Texas, and (iii) Michael
De La Garza and CipherLoc, Inc. v. Tom Wilkinson, Anthony Ambrose, Manchester PR, LLC and Manchester Explorer, LP; Cause No. D-1-GN-19-004708
in the 53 rd Judicial District Court of Travis County, Texas. Under the Settlement, all of the foregoing actions were
dismissed with prejudice. Pursuant to the Settlement, Mr. De La Garza, agreed to, among other things, (i) resign as a director
of the Company and confirmed that he had no disagreements with the Board of Directors, and (ii) return 13,137,757 shares of the
Company’s common stock, $0.01 par value per share (the “Forfeited Stock”), held by him to the Company’s
treasury. We agreed to pay Mr. De La Garza an aggregate sum of $400,000 (the “Settlement Amount”), payable as follows:
(A) $300,000 on or before ten (10) business days after the last to occur (the “Settlement Date”) of (i) the execution
of the Settlement by Mr. De La Garza, (ii) actual receipt by the Company of the Forfeited Stock and consummation of the deliveries
contemplated by the Settlement, and (iii) the receipt by the Company of a completed Internal Revenue Service Form W-9 from Mr.
De La Garza; and (B) $25,000 on each of the four (4) succeeding quarterly anniversaries of the Settlement Date. Notwithstanding
the foregoing, in the event that Mr. De La Garza is not in compliance with the Settlement on any such payment date, then no payment
shall be due and we will have the right to pursue any and all remedies against De La Garza including, without limitation, seeking
the return of all amounts paid. In exchange for the consideration described above, and subject to the terms and conditions set
forth in the Settlement, the Company and Mr. De La Garza mutually agreed to grant each other a general release.
Other
Payments
Skylar,
Olivia and Robin De La Garza , the immediate family members of former CEO Michael De La Garza, earned $52,278, $47,176 and
$53,000, respectively, in compensation for the year ended September 30, 2019. In August 2019, Robin and Skylar De La Garza were
terminated as employees of the Company. The Company also paid $11,394 in educational costs of Skylar De La Garza and $6,200 in
moving expenses of Olivia De La Garza. Michael De La Garza was the CEO and director of the Company during the period of time when
these payments were made.
Review,
Approval or Ratification of Transactions with Related Parties
Our
Board of Directors reviews and approves transactions with directors, officers and holders of five percent or more of our voting
securities and their affiliates, each a related party. The material facts as to a related party’s relationship or interest
in the transaction are disclosed to our Board of Directors prior to their consideration of such transaction. Further, when stockholders
are entitled to vote on a transaction with a related party, the material facts of the related party’s relationship or interest
in the transaction are disclosed to the stockholders, who must approve the transaction in good faith. The Company does not have
a related party transactions policy in place.
ITEM
14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The
aggregate fees billed to the Company by its principal accountants for each of the
last two fiscal years were as follows:
2020
2019
Audit fees
$ 83,200
$ 41,778
Tax fees
$ 12,250
$ 18,500
Total fees
$ 95,450
$ 60,278
Audit
Fees. The aggregate fees billed by Briggs & Veselka Co. for the audit of the Company’s annual financial statements
were $83,200 for the year ended September 30, 2020. The aggregate fees billed by Briggs & Veselka Co. for the audit of the
Company’s annual financial statements were $5,000 for the fiscal year ended September 30, 2019. The aggregate fees billed
by Armanino, LLP of the Company’s interim financial statements were $36,778 for the year ended September 30, 2019.
Audit-Related
Fees. The aggregate fees billed by Briggs & Veselka Co., for assurance and related services that are reasonably related
to the performance of the audit or review of the Company’s financial statements for the fiscal years ended September 30,
2020 and2019 that are not disclosed in the paragraph captioned “Audit Fees” above, were $0.00.
Tax
Fees. The aggregate fee billed by The Wenmohs Group for professional services rendered for tax compliance, tax advice and
tax planning for the fiscal year ended 2020 were $12,250. The aggregate fees billed by Eide Bailly LLP for professional services
rendered for tax compliance, tax advice and tax planning for the fiscal years ended September 30, 2019 were $18,500.
All
Other Fees. The aggregate fees billed by Briggs & Veselka Co. for products and services, other than the services described
in the paragraphs “Audit Fees,” “Audit-Related Fees,” and “Tax Fees” above for the fiscal
years ended September 30, 2020 and 2019 were $0.
The
Board of Directors has received and reviewed the written disclosures and the letter from the Company’s independent registered
public accounting firm required by Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees)
and has discussed with its auditors its independence from the Company. The Board of Directors has considered whether the provision
of services other than audit services is compatible with maintaining auditor independence.
Based
on the review and discussions referred to above, the Board of Directors approved the inclusion of the audited financial statements
be included in the Company’s Annual Report on Form 10-K for its 2020 fiscal year for filing with the SEC.
The
Board of Directors pre-approved all fees described above.
44
PART
IV
ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
3.1
Articles
of Incorporation (incorporated by reference to the Company’s Form 10-SB filed on January 3, 2000).
3.2
Amendment
to the Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K
filed on March 23, 2015).
3.3
Amended
and Restated Bylaws of Cipherloc Corporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report
on Form 8-K, filed on August 30, 2019).
4.1
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
10.1
Employment
Agreement of Michael De La Garza (incorporated by reference to the Company’s Exhibit 10.12 to the Company’s Form
10-K filed on October 10, 2013).
10.2
Employment
Agreement of Dr. Albert Carlson (incorporated by reference to Exhibit 10.15 to the Company’s Current Report on Form
8-K filed on September 4, 2015).
10.3
2019
Stock Incentive Plan, Effective as of August 8, 2019 (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K filed on August 12, 2019.
14.1
Code
of Ethics for Directors, Officers and Employees of Cipherloc and its Affiliates, dated August 8, 2019 (filed as Exhibit 14.1
to a Current Report on Form 8-K, filed on August 12, 2019)
31.1
Certification
of Principal Executive Officer Pursuant to the Securities Exchange Act of 1934, Rules 13a-14 and 15d-14, as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
Certification
of Principal Financial Officer Pursuant to the Securities Exchange Act of 1934, Rules 13a-14 and 15d-14, as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
Certification
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2
Certification
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
45
SIGNATURES
In
accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, there unto duly authorized.
Cipherloc
Corporation
Date:
December 28, 2020
By:
/s/
David Chasteen
David
Chasteen
Chief
Executive Officer, Director
Date:
December 28, 2020
By:
/s/
Ryan Polk
Ryan
Polk
Principal
Financial Officer
In
accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
Company and in the capacities and on the dates indicated.
Date:
December 28, 2020
By:
/s/
David Chasteen
David
Chasteen
Chief
Executive Officer, Director
Date:
December 28, 2020
By:
/s/
Tom Wilkinson
Tom
Wilkinson
Chairman
of the Board of Directors
Date:
December 28, 2020
By:
/s/
Anthony Ambrose
Anthony
Ambrose
Director
Date:
December 28, 2020
By:
/s/
Sammy Davis
Sammy
Davis
Director
Date:
December 28, 2020
By:
/s/
Zeynep Young
Zeynep
Young
Director
46
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.